| Sr. No. | Cat No. | Product Description | Pack Size |
|---|---|---|---|
| 1001 | ICH1209-100mg | Anti-Mouse CD96 (3.3) In Vivo Antibody – Low Endotoxin | 100mg |
| 1002 | ICH1209-25mg | Anti-Mouse CD96 (3.3) In Vivo Antibody – Low Endotoxin | 25mg |
| 1003 | ICH1209-50mg | Anti-Mouse CD96 (3.3) In Vivo Antibody – Low Endotoxin | 50mg |
| 1004 | ICH1209-5mg | Anti-Mouse CD96 (3.3) In Vivo Antibody – Low Endotoxin | 5mg |
| 1005 | ICH1209UL-100mg | Anti-Mouse CD96 (3.3) In Vivo Antibody – Ultra-Low Endotoxin | 100mg |
| 1006 | ICH1209UL-25mg | Anti-Mouse CD96 (3.3) In Vivo Antibody – Ultra-Low Endotoxin | 25mg |
| 1007 | ICH1209UL-50mg | Anti-Mouse CD96 (3.3) In Vivo Antibody – Ultra-Low Endotoxin | 50mg |
| 1008 | ICH1209UL-5mg | Anti-Mouse CD96 (3.3) In Vivo Antibody – Ultra-Low Endotoxin | 5mg |
| 1009 | ICH1210-100mg | Anti-Mouse CD4 (YTS191) In Vivo Antibody – Low Endotoxin | 100mg |
| 1010 | ICH1210-25mg | Anti-Mouse CD4 (YTS191) In Vivo Antibody – Low Endotoxin | 25mg |
| 1011 | ICH1210-50mg | Anti-Mouse CD4 (YTS191) In Vivo Antibody – Low Endotoxin | 50mg |
| 1012 | ICH1210-5mg | Anti-Mouse CD4 (YTS191) In Vivo Antibody – Low Endotoxin | 5mg |
| 1013 | ICH1210UL-100mg | Anti-Mouse CD4 (YTS191) In Vivo Antibody – Ultra-Low Endotoxin | 100mg |
| 1014 | ICH1210UL-25mg | Anti-Mouse CD4 (YTS191) In Vivo Antibody – Ultra-Low Endotoxin | 25mg |
| 1015 | ICH1210UL-50mg | Anti-Mouse CD4 (YTS191) In Vivo Antibody – Ultra-Low Endotoxin | 50mg |
| 1016 | ICH1210UL-5mg | Anti-Mouse CD4 (YTS191) In Vivo Antibody – Ultra-Low Endotoxin | 5mg |
| 1017 | ICH1211-10mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 10mg |
| 1018 | ICH1211-1mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 1mg |
| 1019 | ICH1211-20mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 20mg |
| 1020 | ICH1211-5mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 5mg |
| 1021 | ICH1211LALAPG-10mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody (LALAPG) | 10mg |
| 1022 | ICH1211LALAPG-1mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody (LALAPG) | 1mg |
| 1023 | ICH1211LALAPG-20mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody (LALAPG) | 20mg |
| 1024 | ICH1211LALAPG-5mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody (LALAPG) | 5mg |
| 1025 | ICH1212G1-10mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 10mg |
| 1026 | ICH1212G1-1mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 1mg |
| 1027 | ICH1212G1-20mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 20mg |
| 1028 | ICH1212G1-5mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 5mg |
| 1029 | ICH1212G2-10mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 10mg |
| 1030 | ICH1212G2-1mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 1mg |
| 1031 | ICH1212G2-20mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 20mg |
| 1032 | ICH1212G2-5mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 5mg |
| 1033 | ICH1212HU-10mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 10mg |
| 1034 | ICH1212HU-1mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 1mg |
| 1035 | ICH1212HU-20mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 20mg |
| 1036 | ICH1212HU-5mg | Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody | 5mg |
| 1037 | ICH1213-10mg | Bulk Anti-Myc Tag (9E10) Antibody | 10mg |
| 1038 | ICH1213-1mg | Bulk Anti-Myc Tag (9E10) Antibody | 1mg |
| 1039 | ICH1213-20mg | Bulk Anti-Myc Tag (9E10) Antibody | 20mg |
| 1040 | ICH1213-5mg | Bulk Anti-Myc Tag (9E10) Antibody | 5mg |
| 1041 | ICH1214-100mg | Anti-Mouse MAdCAM-1 (MECA-89) In Vivo Antibody – Low Endotoxin | 100mg |
| 1042 | ICH1214-25mg | Anti-Mouse MAdCAM-1 (MECA-89) In Vivo Antibody – Low Endotoxin | 25mg |
| 1043 | ICH1214-50mg | Anti-Mouse MAdCAM-1 (MECA-89) In Vivo Antibody – Low Endotoxin | 50mg |
| 1044 | ICH1214-5mg | Anti-Mouse MAdCAM-1 (MECA-89) In Vivo Antibody – Low Endotoxin | 5mg |
| 1045 | ICH2243-100mg | Rat IgG2b (1-2) In Vivo Isotype Control – Low Endotoxin | 100mg |
| 1046 | ICH2243-25mg | Rat IgG2b (1-2) In Vivo Isotype Control – Low Endotoxin | 25mg |
| 1047 | ICH2243-50mg | Rat IgG2b (1-2) In Vivo Isotype Control – Low Endotoxin | 50mg |
| 1048 | ICH2243-5mg | Rat IgG2b (1-2) In Vivo Isotype Control – Low Endotoxin | 5mg |
| 1049 | ICH2243UL-100mg | Rat IgG2b (1-2) In Vivo Isotype Control – Ultra-Low Endotoxin | 100mg |
| 1050 | ICH2243UL-25mg | Rat IgG2b (1-2) In Vivo Isotype Control – Ultra-Low Endotoxin | 25mg |
| 1051 | ICH2243UL-50mg | Rat IgG2b (1-2) In Vivo Isotype Control – Ultra-Low Endotoxin | 50mg |
| 1052 | ICH2243UL-5mg | Rat IgG2b (1-2) In Vivo Isotype Control – Ultra-Low Endotoxin | 5mg |
| 1053 | ICH2244-100mg | Rat IgG2a (1-1) In Vivo Isotype Control Low Endotoxin | 100mg |
| 1054 | ICH2244-25mg | Rat IgG2a (1-1) In Vivo Isotype Control Low Endotoxin | 25mg |
| 1055 | ICH2244-50mg | Rat IgG2a (1-1) In Vivo Isotype Control Low Endotoxin | 50mg |
| 1056 | ICH2244-5mg | Rat IgG2a (1-1) In Vivo Isotype Control Low Endotoxin | 5mg |
| 1057 | ICH2244EC5-100mg | Rat IgG2a (1-1) In Vivo Isotype Control Low Endotoxin – 5mg/ml | 100mg |
| 1058 | ICH2244EC5-25mg | Rat IgG2a (1-1) In Vivo Isotype Control Low Endotoxin – 5mg/ml | 25mg |
| 1059 | ICH2244EC5-50mg | Rat IgG2a (1-1) In Vivo Isotype Control Low Endotoxin – 5mg/ml | 50mg |
| 1060 | ICH2244EC5-5mg | Rat IgG2a (1-1) In Vivo Isotype Control Low Endotoxin – 5mg/ml | 5mg |
| 1061 | ICH2244UL-100mg | Rat IgG2a (1-1) In Vivo Isotype Control Ultra-Low Endotoxin | 100mg |
| 1062 | ICH2244UL-25mg | Rat IgG2a (1-1) In Vivo Isotype Control Ultra-Low Endotoxin | 25mg |
| 1063 | ICH2244UL-50mg | Rat IgG2a (1-1) In Vivo Isotype Control Ultra-Low Endotoxin | 50mg |
| 1064 | ICH2244UL-5mg | Rat IgG2a (1-1) In Vivo Isotype Control Ultra-Low Endotoxin | 5mg |
| 1065 | ICH2244ULEC5-100mg | Rat IgG2a (1-1) In Vivo Isotype Control Ultra-Low Endotoxin – 5mg/ml | 100mg |
| 1066 | ICH2244ULEC5-25mg | Rat IgG2a (1-1) In Vivo Isotype Control Ultra-Low Endotoxin – 5mg/ml | 25mg |
| 1067 | ICH2244ULEC5-50mg | Rat IgG2a (1-1) In Vivo Isotype Control Ultra-Low Endotoxin – 5mg/ml | 50mg |
| 1068 | ICH2244ULEC5-5mg | Rat IgG2a (1-1) In Vivo Isotype Control Ultra-Low Endotoxin – 5mg/ml | 5mg |
| 1069 | ICH2245-100mg | Mouse IgG2a (C1.18.4) Isotype Control for In Vivo – Low Endotoxin | 100mg |
| 1070 | ICH2245-25mg | Mouse IgG2a (C1.18.4) Isotype Control for In Vivo – Low Endotoxin | 25mg |
| 1071 | ICH2245-50mg | Mouse IgG2a (C1.18.4) Isotype Control for In Vivo – Low Endotoxin | 50mg |
| 1072 | ICH2245-5mg | Mouse IgG2a (C1.18.4) Isotype Control for In Vivo – Low Endotoxin | 5mg |
| 1073 | ICH2245UL-100mg | Mouse IgG2a (C1.18.4) Isotype Control for In Vivo – Ultra-Low Endotoxin | 100mg |
| 1074 | ICH2245UL-25mg | Mouse IgG2a (C1.18.4) Isotype Control for In Vivo – Ultra-Low Endotoxin | 25mg |
| 1075 | ICH2245UL-50mg | Mouse IgG2a (C1.18.4) Isotype Control for In Vivo – Ultra-Low Endotoxin | 50mg |
| 1076 | ICH2245UL-5mg | Mouse IgG2a (C1.18.4) Isotype Control for In Vivo – Ultra-Low Endotoxin | 5mg |
| 1077 | ICH2246-100mg | Rat IgG1 (GL113) Isotype Control for In Vivo Low Endotoxin | 100mg |
| 1078 | ICH2246-25mg | Rat IgG1 (GL113) Isotype Control for In Vivo Low Endotoxin | 25mg |
| 1079 | ICH2246-50mg | Rat IgG1 (GL113) Isotype Control for In Vivo Low Endotoxin | 50mg |
| 1080 | ICH2246-5mg | Rat IgG1 (GL113) Isotype Control for In Vivo Low Endotoxin | 5mg |
| 1081 | ICH2246UL-100mg | Rat IgG1 (GL113) Isotype Control for In Vivo Ultra-Low Endotoxin | 100mg |
| 1082 | ICH2246UL-25mg | Rat IgG1 (GL113) Isotype Control for In Vivo Ultra-Low Endotoxin | 25mg |
| 1083 | ICH2246UL-50mg | Rat IgG1 (GL113) Isotype Control for In Vivo Ultra-Low Endotoxin | 50mg |
| 1084 | ICH2246UL-5mg | Rat IgG1 (GL113) Isotype Control for In Vivo Ultra-Low Endotoxin | 5mg |
| 1085 | ICH2247-100mg | Mouse IgG1 (HKSP) Isotype Control for In Vivo – Low Endotoxin | 100mg |
| 1086 | ICH2247-25mg | Mouse IgG1 (HKSP) Isotype Control for In Vivo – Low Endotoxin | 25mg |
| 1087 | ICH2247-50mg | Mouse IgG1 (HKSP) Isotype Control for In Vivo – Low Endotoxin | 50mg |
| 1088 | ICH2247-5mg | Mouse IgG1 (HKSP) Isotype Control for In Vivo – Low Endotoxin | 5mg |
| 1089 | ICH2247UL-100mg | Mouse IgG1 (HKSP) Isotype Control for In Vivo – Ultra-Low Endotoxin | 100mg |
| 1090 | ICH2247UL-25mg | Mouse IgG1 (HKSP) Isotype Control for In Vivo – Ultra-Low Endotoxin | 25mg |
| 1091 | ICH2247UL-50mg | Mouse IgG1 (HKSP) Isotype Control for In Vivo – Ultra-Low Endotoxin | 50mg |
| 1092 | ICH2247UL-5mg | Mouse IgG1 (HKSP) Isotype Control for In Vivo – Ultra-Low Endotoxin | 5mg |
| 1093 | ICH2248-100mg | Mouse IgG1 (HKSP84) Isotype Control for In Vivo – Low Endotoxin | 100mg |
| 1094 | ICH2248-25mg | Mouse IgG1 (HKSP84) Isotype Control for In Vivo – Low Endotoxin | 25mg |
| 1095 | ICH2248-50mg | Mouse IgG1 (HKSP84) Isotype Control for In Vivo – Low Endotoxin | 50mg |
| 1096 | ICH2248-5mg | Mouse IgG1 (HKSP84) Isotype Control for In Vivo – Low Endotoxin | 5mg |
| 1097 | ICH2248UL-100mg | Mouse IgG1 (HKSP84) Isotype Control for In Vivo – Ultra-Low Endotoxin | 100mg |
| 1098 | ICH2248UL-25mg | Mouse IgG1 (HKSP84) Isotype Control for In Vivo – Ultra-Low Endotoxin | 25mg |
| 1099 | ICH2248UL-50mg | Mouse IgG1 (HKSP84) Isotype Control for In Vivo – Ultra-Low Endotoxin | 50mg |
| 1100 | ICH2248UL-5mg | Mouse IgG1 (HKSP84) Isotype Control for In Vivo – Ultra-Low Endotoxin | 5mg |
| 1101 | ICH2249-100mg | Mouse IgG3 Isotype Control for In Vivo – Low Endotoxin (MG3-35) [ICH2249] | 100mg |
| 1102 | ICH2249-25mg | Mouse IgG3 Isotype Control for In Vivo – Low Endotoxin (MG3-35) [ICH2249] | 25mg |
| 1103 | ICH2249-50mg | Mouse IgG3 Isotype Control for In Vivo – Low Endotoxin (MG3-35) [ICH2249] | 50mg |
| 1104 | ICH2249-5mg | Mouse IgG3 Isotype Control for In Vivo – Low Endotoxin (MG3-35) [ICH2249] | 5mg |
| 1105 | ICH2249UL-100mg | Mouse IgG3 Isotype Control for In Vivo – Ultra-Low Endotoxin (MG3-35) [ICH2249] | 100mg |
| 1106 | ICH2249UL-25mg | Mouse IgG3 Isotype Control for In Vivo – Ultra-Low Endotoxin (MG3-35) [ICH2249] | 25mg |
| 1107 | ICH2249UL-50mg | Mouse IgG3 Isotype Control for In Vivo – Ultra-Low Endotoxin (MG3-35) [ICH2249] | 50mg |
| 1108 | ICH2249UL-5mg | Mouse IgG3 Isotype Control for In Vivo – Ultra-Low Endotoxin (MG3-35) [ICH2249] | 5mg |
| 1109 | ICH2250-100mg | Mouse IgG2b (MPC-11) Isotype Control for In Vivo – Low Endotoxin | 100mg |
| 1110 | ICH2250-25mg | Mouse IgG2b (MPC-11) Isotype Control for In Vivo – Low Endotoxin | 25mg |
| 1111 | ICH2250-50mg | Mouse IgG2b (MPC-11) Isotype Control for In Vivo – Low Endotoxin | 50mg |
| 1112 | ICH2250-5mg | Mouse IgG2b (MPC-11) Isotype Control for In Vivo – Low Endotoxin | 5mg |
| 1113 | ICH2250UL-100mg | Mouse IgG2b (MPC-11) Isotype Control for In Vivo – Ultra-Low Endotoxin | 100mg |
| 1114 | ICH2250UL-25mg | Mouse IgG2b (MPC-11) Isotype Control for In Vivo – Ultra-Low Endotoxin | 25mg |
| 1115 | ICH2250UL-50mg | Mouse IgG2b (MPC-11) Isotype Control for In Vivo – Ultra-Low Endotoxin | 50mg |
| 1116 | ICH2250UL-5mg | Mouse IgG2b (MPC-11) Isotype Control for In Vivo – Ultra-Low Endotoxin | 5mg |
| 1117 | ICH2251-100mg | Armenian Hamster IgG (PIP) Isotype Control for In Vivo – Low Endotoxin | 100mg |
| 1118 | ICH2251-25mg | Armenian Hamster IgG (PIP) Isotype Control for In Vivo – Low Endotoxin | 25mg |
| 1119 | ICH2251-50mg | Armenian Hamster IgG (PIP) Isotype Control for In Vivo – Low Endotoxin | 50mg |
| 1120 | ICH2251-5mg | Armenian Hamster IgG (PIP) Isotype Control for In Vivo – Low Endotoxin | 5mg |
| 1121 | ICH2251UL-100mg | Armenian Hamster IgG (PIP) Isotype Control for In Vivo – Ultra-Low Endotoxin | 100mg |
| 1122 | ICH2251UL-25mg | Armenian Hamster IgG (PIP) Isotype Control for In Vivo – Ultra-Low Endotoxin | 25mg |
| 1123 | ICH2251UL-50mg | Armenian Hamster IgG (PIP) Isotype Control for In Vivo – Ultra-Low Endotoxin | 50mg |
| 1124 | ICH2251UL-5mg | Armenian Hamster IgG (PIP) Isotype Control for In Vivo – Ultra-Low Endotoxin | 5mg |
| 1125 | ICH2252-100mg | Mouse IgM Isotype Control for In Vivo – Low Endotoxin | 100mg |
| 1126 | ICH2252-25mg | Mouse IgM Isotype Control for In Vivo – Low Endotoxin | 25mg |
| 1127 | ICH2252-50mg | Mouse IgM Isotype Control for In Vivo – Low Endotoxin | 50mg |
| 1128 | ICH2252-5mg | Mouse IgM Isotype Control for In Vivo – Low Endotoxin | 5mg |
| 1129 | ICH2252UL-100mg | Mouse IgM Isotype Control for In Vivo – Ultra-Low Endotoxin | 100mg |
| 1130 | ICH2252UL-25mg | Mouse IgM Isotype Control for In Vivo – Ultra-Low Endotoxin | 25mg |
| 1131 | ICH2252UL-50mg | Mouse IgM Isotype Control for In Vivo – Ultra-Low Endotoxin | 50mg |
| 1132 | ICH2252UL-5mg | Mouse IgM Isotype Control for In Vivo – Ultra-Low Endotoxin | 5mg |
| 1133 | ICH2253-100mg | Syrian Hamster IgG Isotype Control for In Vivo – Low Endotoxin | 100mg |
| 1134 | ICH2253-25mg | Syrian Hamster IgG Isotype Control for In Vivo – Low Endotoxin | 25mg |
| 1135 | ICH2253-50mg | Syrian Hamster IgG Isotype Control for In Vivo – Low Endotoxin | 50mg |
| 1136 | ICH2253-5mg | Syrian Hamster IgG Isotype Control for In Vivo – Low Endotoxin | 5mg |
| 1137 | ICH2254-100mg | Bulk Human IgG1 (IB1) Isotype Control | 100mg |
| 1138 | ICH2254-25mg | Bulk Human IgG1 (IB1) Isotype Control | 25mg |
| 1139 | ICH2254-50mg | Bulk Human IgG1 (IB1) Isotype Control | 50mg |
| 1140 | ICH2254-5mg | Bulk Human IgG1 (IB1) Isotype Control | 5mg |
| 1141 | ICH2254D265A-100mg | Bulk Human IgG1 (IB1) Isotype Control D265A | 100mg |
| 1142 | ICH2254D265A-10mg | Bulk Human IgG1 (IB1) Isotype Control D265A | 10mg |
| 1143 | ICH2254D265A-1mg | Bulk Human IgG1 (IB1) Isotype Control D265A | 1mg |
| 1144 | ICH2254D265A-20mg | Bulk Human IgG1 (IB1) Isotype Control D265A | 20mg |
| 1145 | ICH2254D265A-50mg | Bulk Human IgG1 (IB1) Isotype Control D265A | 50mg |
| 1146 | ICH2254D265A-5mg | Bulk Human IgG1 (IB1) Isotype Control D265A | 5mg |
| 1147 | ICH2254D265AN297A-100mg | Bulk Human IgG1 (IB1) Isotype Control D265A/N297A | 100mg |
| 1148 | ICH2254D265AN297A-10mg | Bulk Human IgG1 (IB1) Isotype Control D265A/N297A | 10mg |
| 1149 | ICH2254D265AN297A-1mg | Bulk Human IgG1 (IB1) Isotype Control D265A/N297A | 1mg |
| 1150 | ICH2254D265AN297A-20mg | Bulk Human IgG1 (IB1) Isotype Control D265A/N297A | 20mg |
| 1151 | ICH2254D265AN297A-50mg | Bulk Human IgG1 (IB1) Isotype Control D265A/N297A | 50mg |
| 1152 | ICH2254D265AN297A-5mg | Bulk Human IgG1 (IB1) Isotype Control D265A/N297A | 5mg |
| 1153 | ICH2254LALA-100mg | Bulk Human IgG1 (IB1) Isotype Control LALA | 100mg |
| 1154 | ICH2254LALA-10mg | Bulk Human IgG1 (IB1) Isotype Control LALA | 10mg |
| 1155 | ICH2254LALA-1mg | Bulk Human IgG1 (IB1) Isotype Control LALA | 1mg |
| 1156 | ICH2254LALA-20mg | Bulk Human IgG1 (IB1) Isotype Control LALA | 20mg |
| 1157 | ICH2254LALA-50mg | Bulk Human IgG1 (IB1) Isotype Control LALA | 50mg |
| 1158 | ICH2254LALA-5mg | Bulk Human IgG1 (IB1) Isotype Control LALA | 5mg |
| 1159 | ICH2254LALAPG-100mg | Bulk Human IgG1 (IB1) Isotype Control LALAPG | 100mg |
| 1160 | ICH2254LALAPG-10mg | Bulk Human IgG1 (IB1) Isotype Control LALAPG | 10mg |
| 1161 | ICH2254LALAPG-1mg | Bulk Human IgG1 (IB1) Isotype Control LALAPG | 1mg |
| 1162 | ICH2254LALAPG-20mg | Bulk Human IgG1 (IB1) Isotype Control LALAPG | 20mg |
| 1163 | ICH2254LALAPG-50mg | Bulk Human IgG1 (IB1) Isotype Control LALAPG | 50mg |
| 1164 | ICH2254LALAPG-5mg | Bulk Human IgG1 (IB1) Isotype Control LALAPG | 5mg |
| 1165 | ICH2254N297A-100mg | Bulk Human IgG1 (IB1) Isotype Control N297A | 100mg |
| 1166 | ICH2254N297A-10mg | Bulk Human IgG1 (IB1) Isotype Control N297A | 10mg |
| 1167 | ICH2254N297A-1mg | Bulk Human IgG1 (IB1) Isotype Control N297A | 1mg |
| 1168 | ICH2254N297A-20mg | Bulk Human IgG1 (IB1) Isotype Control N297A | 20mg |
| 1169 | ICH2254N297A-50mg | Bulk Human IgG1 (IB1) Isotype Control N297A | 50mg |
| 1170 | ICH2254N297A-5mg | Bulk Human IgG1 (IB1) Isotype Control N297A | 5mg |
| 1171 | ICH2254SELF-100mg | Bulk Human IgG1 (IB1) Isotype Control SELF | 100mg |
| 1172 | ICH2254SELF-10mg | Bulk Human IgG1 (IB1) Isotype Control SELF | 10mg |
| 1173 | ICH2254SELF-1mg | Bulk Human IgG1 (IB1) Isotype Control SELF | 1mg |
| 1174 | ICH2254SELF-20mg | Bulk Human IgG1 (IB1) Isotype Control SELF | 20mg |
| 1175 | ICH2254SELF-50mg | Bulk Human IgG1 (IB1) Isotype Control SELF | 50mg |
| 1176 | ICH2254SELF-5mg | Bulk Human IgG1 (IB1) Isotype Control SELF | 5mg |
| 1177 | ICH2255-100mg | Bulk Human IgG2 (IB2) Isotype Control | 100mg |
| 1178 | ICH2255-25mg | Bulk Human IgG2 (IB2) Isotype Control | 25mg |
| 1179 | ICH2255-50mg | Bulk Human IgG2 (IB2) Isotype Control | 50mg |
| 1180 | ICH2255-5mg | Bulk Human IgG2 (IB2) Isotype Control | 5mg |
| 1181 | ICH2256-100mg | Bulk Human IgG3 (IB3) Isotype Control | 100mg |
| 1182 | ICH2256-25mg | Bulk Human IgG3 (IB3) Isotype Control | 25mg |
| 1183 | ICH2256-50mg | Bulk Human IgG3 (IB3) Isotype Control | 50mg |
| 1184 | ICH2256-5mg | Bulk Human IgG3 (IB3) Isotype Control | 5mg |
| 1185 | ICH2257-100mg | Bulk Human IgG4 (IB4) Isotype Control | 100mg |
| 1186 | ICH2257-25mg | Bulk Human IgG4 (IB4) Isotype Control | 25mg |
| 1187 | ICH2257-50mg | Bulk Human IgG4 (IB4) Isotype Control | 50mg |
| 1188 | ICH2257-5mg | Bulk Human IgG4 (IB4) Isotype Control | 5mg |
| 1189 | ICH2257ELS228P-100mg | Bulk Human IgG4 (IB4) Isotype Control – Extremely Low Endotoxin | 100mg |
| 1190 | ICH2257ELS228P-10mg | Bulk Human IgG4 (IB4) Isotype Control – Extremely Low Endotoxin | 10mg |
| 1191 | ICH2257ELS228P-20mg | Bulk Human IgG4 (IB4) Isotype Control – Extremely Low Endotoxin | 20mg |
| 1192 | ICH2257ELS228P-50mg | Bulk Human IgG4 (IB4) Isotype Control – Extremely Low Endotoxin | 50mg |
| 1193 | ICH2257ELS228P-5mg | Bulk Human IgG4 (IB4) Isotype Control – Extremely Low Endotoxin | 5mg |
| 1194 | ICH2257S228P-100mg | Bulk Human IgG4 (IB4) Isotype Control S228P | 100mg |
| 1195 | ICH2257S228P-10mg | Bulk Human IgG4 (IB4) Isotype Control S228P | 10mg |
| 1196 | ICH2257S228P-20mg | Bulk Human IgG4 (IB4) Isotype Control S228P | 20mg |
| 1197 | ICH2257S228P-50mg | Bulk Human IgG4 (IB4) Isotype Control S228P | 50mg |
| 1198 | ICH2257S228P-5mg | Bulk Human IgG4 (IB4) Isotype Control S228P | 5mg |
| 1199 | ICH2257SPLEPG-100mg | Bulk Human IgG4 (IB4) Isotype Control SPLEPG | 100mg |
| 1200 | ICH2257SPLEPG-10mg | Bulk Human IgG4 (IB4) Isotype Control SPLEPG | 10mg |
| 1201 | ICH2257SPLEPG-1mg | Bulk Human IgG4 (IB4) Isotype Control SPLEPG | 1mg |
| 1202 | ICH2257SPLEPG-20mg | Bulk Human IgG4 (IB4) Isotype Control SPLEPG | 20mg |
| 1203 | ICH2257SPLEPG-50mg | Bulk Human IgG4 (IB4) Isotype Control SPLEPG | 50mg |
| 1204 | ICH2257SPLEPG-5mg | Bulk Human IgG4 (IB4) Isotype Control SPLEPG | 5mg |
| 1205 | ICH2258D265A-100mg | Mouse IgG1 (IB5) Isotype Control D265A for In Vivo | 100mg |
| 1206 | ICH2258D265A-10mg | Mouse IgG1 (IB5) Isotype Control D265A for In Vivo | 10mg |
| 1207 | ICH2258D265A-1mg | Mouse IgG1 (IB5) Isotype Control D265A for In Vivo | 1mg |
| 1208 | ICH2258D265A-20mg | Mouse IgG1 (IB5) Isotype Control D265A for In Vivo | 20mg |
| 1209 | ICH2258D265A-50mg | Mouse IgG1 (IB5) Isotype Control D265A for In Vivo | 50mg |
| 1210 | ICH2258D265A-5mg | Mouse IgG1 (IB5) Isotype Control D265A for In Vivo | 5mg |
| 1211 | ICH2259LALAPG-100mg | Mouse IgG2a Isotype Control – LALAPG | 100mg |
| 1212 | ICH2259LALAPG-20mg | Mouse IgG2a Isotype Control – LALAPG | 20mg |
| 1213 | ICH2259LALAPG-50mg | Mouse IgG2a Isotype Control – LALAPG | 50mg |
| 1214 | ICH2259LALAPG-5mg | Mouse IgG2a Isotype Control – LALAPG | 5mg |
| 1215 | ICH3001-100ml | In Vivo Buffer pH5.0 | 100ml |
| 1216 | ICH3002-100ml | In Vivo Buffer pH7.4 | 100ml |
| 1217 | ICH3003-100ml | In Vivo Buffer pH8.0 | 100ml |
| 1218 | ICH4001-100mg | Adalimumab Biosimilar – Research Grade | 100mg |
| 1219 | ICH4001-10mg | Adalimumab Biosimilar – Research Grade | 10mg |
| 1220 | ICH4001-1mg | Adalimumab Biosimilar – Research Grade | 1mg |
| 1221 | ICH4001-20mg | Adalimumab Biosimilar – Research Grade | 20mg |
| 1222 | ICH4001-50mg | Adalimumab Biosimilar – Research Grade | 50mg |
| 1223 | ICH4001-5mg | Adalimumab Biosimilar – Research Grade | 5mg |
| 1224 | ICH4001APC-50ug | Adalimumab Biosimilar – APC Research Grade | 50ug |
| 1225 | ICH4001B-0.1mg | Adalimumab Biosimilar – Biotin Research Grade | 100ug |
| 1226 | ICH4001D488-0.1mg | Adalimumab Biosimilar – Dylight488 Research Grade | 100ug |
| 1227 | ICH4001HRP-0.1mg | Adalimumab Biosimilar – HRP Research Grade | 100ug |
| 1228 | ICH4002-100mg | Alemtuzumab Biosimilar – Research Grade | 100mg |
| 1229 | ICH4002-10mg | Alemtuzumab Biosimilar – Research Grade | 10mg |
| 1230 | ICH4002-1mg | Alemtuzumab Biosimilar – Research Grade | 1mg |
| 1231 | ICH4002-20mg | Alemtuzumab Biosimilar – Research Grade | 20mg |
| 1232 | ICH4002-50mg | Alemtuzumab Biosimilar – Research Grade | 50mg |
| 1233 | ICH4002-5mg | Alemtuzumab Biosimilar – Research Grade | 5mg |
| 1234 | ICH4002APC-50ug | Alemtuzumab Biosimilar – APC Research Grade | 50ug |
| 1235 | ICH4002B-0.1mg | Alemtuzumab Biosimilar – Biotin Research Grade | 100ug |
| 1236 | ICH4002D488-0.1mg | Alemtuzumab Biosimilar – Dylight488 Research Grade | 100ug |
| 1237 | ICH4002HRP-0.1mg | Alemtuzumab Biosimilar – HRP Research Grade | 100ug |
| 1238 | ICH4002PE-50ug | Alemtuzumab Biosimilar – PE Research Grade | 50ug |
| 1239 | ICH4003-100mg | Bevacizumab Biosimilar – Research Grade | 100mg |
| 1240 | ICH4003-10mg | Bevacizumab Biosimilar – Research Grade | 10mg |
| 1241 | ICH4003-1mg | Bevacizumab Biosimilar – Research Grade | 1mg |
| 1242 | ICH4003-20mg | Bevacizumab Biosimilar – Research Grade | 20mg |
| 1243 | ICH4003-50mg | Bevacizumab Biosimilar – Research Grade | 50mg |
| 1244 | ICH4003-5mg | Bevacizumab Biosimilar – Research Grade | 5mg |
| 1245 | ICH4003B-0.1mg | Bevacizumab Biosimilar – Biotin Research Grade | 100ug |
| 1246 | ICH4003HRP-0.1mg | Bevacizumab Biosimilar – HRP Research Grade | 100ug |
| 1247 | ICH4004-100mg | Cetuximab Biosimilar – Research Grade | 100mg |
| 1248 | ICH4004-10mg | Cetuximab Biosimilar – Research Grade | 10mg |
| 1249 | ICH4004-1mg | Cetuximab Biosimilar – Research Grade | 1mg |
| 1250 | ICH4004-20mg | Cetuximab Biosimilar – Research Grade | 20mg |
| 1251 | ICH4004-50mg | Cetuximab Biosimilar – Research Grade | 50mg |
| 1252 | ICH4004-5mg | Cetuximab Biosimilar – Research Grade | 5mg |
| 1253 | ICH4004APC-50ug | Cetuximab Biosimilar – APC Research Grade | 50ug |
| 1254 | ICH4004D488-0.1mg | Cetuximab Biosimilar – Dylight488 Research Grade | 100ug |
| 1255 | ICH4004Fc-100mg | Cetuximab Biosimilar – GAALIE Research Grade | 100mg |
| 1256 | ICH4004Fc-10mg | Cetuximab Biosimilar – GAALIE Research Grade | 10mg |
| 1257 | ICH4004Fc-1mg | Cetuximab Biosimilar – GAALIE Research Grade | 1mg |
| 1258 | ICH4004Fc-20mg | Cetuximab Biosimilar – GAALIE Research Grade | 20mg |
| 1259 | ICH4004Fc-50mg | Cetuximab Biosimilar – GAALIE Research Grade | 50mg |
| 1260 | ICH4004Fc-5mg | Cetuximab Biosimilar – GAALIE Research Grade | 5mg |
| 1261 | ICH4004PE-50ug | Cetuximab Biosimilar – PE Research Grade | 50ug |
| 1262 | ICH4005-100mg | Eculizumab Biosimilar – Research Grade | 100mg |
| 1263 | ICH4005-10mg | Eculizumab Biosimilar – Research Grade | 10mg |
| 1264 | ICH4005-1mg | Eculizumab Biosimilar – Research Grade | 1mg |
| 1265 | ICH4005-20mg | Eculizumab Biosimilar – Research Grade | 20mg |
| 1266 | ICH4005-50mg | Eculizumab Biosimilar – Research Grade | 50mg |
| 1267 | ICH4005-5mg | Eculizumab Biosimilar – Research Grade | 5mg |
| 1268 | ICH4006-100mg | Infliximab Biosimilar – Research Grade | 100mg |
| 1269 | ICH4006-10mg | Infliximab Biosimilar – Research Grade | 10mg |
| 1270 | ICH4006-1mg | Infliximab Biosimilar – Research Grade | 1mg |
| 1271 | ICH4006-20mg | Infliximab Biosimilar – Research Grade | 20mg |
| 1272 | ICH4006-50mg | Infliximab Biosimilar – Research Grade | 50mg |
| 1273 | ICH4006-5mg | Infliximab Biosimilar – Research Grade | 5mg |
| 1274 | ICH4007-100mg | Matuzumab Biosimilar – Research Grade | 100mg |
| 1275 | ICH4007-10mg | Matuzumab Biosimilar – Research Grade | 10mg |
| 1276 | ICH4007-1mg | Matuzumab Biosimilar – Research Grade | 1mg |
| 1277 | ICH4007-20mg | Matuzumab Biosimilar – Research Grade | 20mg |
| 1278 | ICH4007-50mg | Matuzumab Biosimilar – Research Grade | 50mg |
| 1279 | ICH4007-5mg | Matuzumab Biosimilar – Research Grade | 5mg |
| 1280 | ICH4008-100mg | Nimotuzumab Biosimilar – Research Grade | 100mg |
| 1281 | ICH4008-10mg | Nimotuzumab Biosimilar – Research Grade | 10mg |
| 1282 | ICH4008-1mg | Nimotuzumab Biosimilar – Research Grade | 1mg |
| 1283 | ICH4008-20mg | Nimotuzumab Biosimilar – Research Grade | 20mg |
| 1284 | ICH4008-50mg | Nimotuzumab Biosimilar – Research Grade | 50mg |
| 1285 | ICH4008-5mg | Nimotuzumab Biosimilar – Research Grade | 5mg |
| 1286 | ICH4009-100mg | Nivolumab Biosimilar – Research Grade | 100mg |
| 1287 | ICH4009-10mg | Nivolumab Biosimilar – Research Grade | 10mg |
| 1288 | ICH4009-1mg | Nivolumab Biosimilar – Research Grade | 1mg |
| 1289 | ICH4009-20mg | Nivolumab Biosimilar – Research Grade | 20mg |
| 1290 | ICH4009-50mg | Nivolumab Biosimilar – Research Grade | 50mg |
| 1291 | ICH4009-5mg | Nivolumab Biosimilar – Research Grade | 5mg |
| 1292 | ICH4009APC-50ug | Nivolumab Biosimilar – Research Grade: APC | 50ug |
| 1293 | ICH4009D488-0.1mg | Nivolumab Biosimilar – Dylight488 Research Grade | 100ug |
| 1294 | ICH4009PE-50ug | Nivolumab Biosimilar – PE Research Grade | 50ug |
| 1295 | ICH4010-100mg | Omalizumab Biosimilar – Research Grade | 100mg |
| 1296 | ICH4010-10mg | Omalizumab Biosimilar – Research Grade | 10mg |
| 1297 | ICH4010-1mg | Omalizumab Biosimilar – Research Grade | 1mg |
| 1298 | ICH4010-20mg | Omalizumab Biosimilar – Research Grade | 20mg |
| 1299 | ICH4010-50mg | Omalizumab Biosimilar – Research Grade | 50mg |
| 1300 | ICH4010-5mg | Omalizumab Biosimilar – Research Grade | 5mg |
| 1301 | ICH4011-100mg | Rituximab Biosimilar – Research Grade | 100mg |
| 1302 | ICH4011-10mg | Rituximab Biosimilar – Research Grade | 10mg |
| 1303 | ICH4011-1mg | Rituximab Biosimilar – Research Grade | 1mg |
| 1304 | ICH4011-20mg | Rituximab Biosimilar – Research Grade | 20mg |
| 1305 | ICH4011-50mg | Rituximab Biosimilar – Research Grade | 50mg |
| 1306 | ICH4011-5mg | Rituximab Biosimilar – Research Grade | 5mg |
| 1307 | ICH4011APC-50ug | Rituximab Biosimilar – Research Grade: APC | 50ug |
| 1308 | ICH4011D488-0.1mg | Rituximab Biosimilar – Dylight488 Research Grade | 100ug |
| 1309 | ICH4011LALAPG-100mg | Rituximab Biosimilar (LALAPG) – Research Grade | 100mg |
| 1310 | ICH4011LALAPG-10mg | Rituximab Biosimilar (LALAPG) – Research Grade | 10mg |
| 1311 | ICH4011LALAPG-1mg | Rituximab Biosimilar (LALAPG) – Research Grade | 1mg |
| 1312 | ICH4011LALAPG-20mg | Rituximab Biosimilar (LALAPG) – Research Grade | 20mg |
| 1313 | ICH4011LALAPG-50mg | Rituximab Biosimilar (LALAPG) – Research Grade | 50mg |
| 1314 | ICH4011LALAPG-5mg | Rituximab Biosimilar (LALAPG) – Research Grade | 5mg |
| 1315 | ICH4011N297A-100mg | Rituximab Biosimilar N297A Research Grade | 100mg |
| 1316 | ICH4011N297A-10mg | Rituximab Biosimilar N297A Research Grade | 10mg |
| 1317 | ICH4011N297A-1mg | Rituximab Biosimilar N297A Research Grade | 1mg |
| 1318 | ICH4011N297A-20mg | Rituximab Biosimilar N297A Research Grade | 20mg |
| 1319 | ICH4011N297A-50mg | Rituximab Biosimilar N297A Research Grade | 50mg |
| 1320 | ICH4011N297A-5mg | Rituximab Biosimilar N297A Research Grade | 5mg |
| 1321 | ICH4012-100mg | Tocilizumab Biosimilar – Research Grade | 100mg |
| 1322 | ICH4012-10mg | Tocilizumab Biosimilar – Research Grade | 10mg |
| 1323 | ICH4012-1mg | Tocilizumab Biosimilar – Research Grade | 1mg |
| 1324 | ICH4012-20mg | Tocilizumab Biosimilar – Research Grade | 20mg |
| 1325 | ICH4012-50mg | Tocilizumab Biosimilar – Research Grade | 50mg |
| 1326 | ICH4012-5mg | Tocilizumab Biosimilar – Research Grade | 5mg |
| 1327 | ICH4013-100mg | Trastuzumab Biosimilar – Research Grade | 100mg |
| 1328 | ICH4013-10mg | Trastuzumab Biosimilar – Research Grade | 10mg |
| 1329 | ICH4013-1mg | Trastuzumab Biosimilar – Research Grade | 1mg |
| 1330 | ICH4013-20mg | Trastuzumab Biosimilar – Research Grade | 20mg |
| 1331 | ICH4013-50mg | Trastuzumab Biosimilar – Research Grade | 50mg |
| 1332 | ICH4013-5mg | Trastuzumab Biosimilar – Research Grade | 5mg |
| 1333 | ICH4013APC-50ug | Trastuzumab Biosimilar – APC Research Grade | 50ug |
| 1334 | ICH4013B-0.1mg | Trastuzumab Biosimilar – Biotin Research Grade | 100ug |
| 1335 | ICH4013D488-0.1mg | Trastuzumab Biosimilar – Dylight488 Research Grade | 100ug |
| 1336 | ICH4013HRP-0.1mg | Trastuzumab Biosimilar – HRP Research Grade | 100ug |
| 1337 | ICH4013PE-50ug | Trastuzumab Biosimilar – PE Research Grade | 50ug |
| 1338 | ICH4014-20mg | Ado-Trastuzumab Emtansine Biosimilar – Research Grade | 20mg |
| 1339 | ICH4014-5mg | Ado-Trastuzumab Emtansine Biosimilar – Research Grade | 5mg |
| 1340 | ICH4015-1mg | Aflibercept Biosimilar – Research Grade | 1mg |
| 1341 | ICH4015-20mg | Aflibercept Biosimilar – Research Grade | 20mg |
| 1342 | ICH4015-5mg | Aflibercept Biosimilar – Research Grade | 5mg |
| 1343 | ICH4016-100mg | Alirocumab Biosimilar – Research Grade | 100mg |
| 1344 | ICH4016-10mg | Alirocumab Biosimilar – Research Grade | 10mg |
| 1345 | ICH4016-1mg | Alirocumab Biosimilar – Research Grade | 1mg |
| 1346 | ICH4016-20mg | Alirocumab Biosimilar – Research Grade | 20mg |
| 1347 | ICH4016-50mg | Alirocumab Biosimilar – Research Grade | 50mg |
| 1348 | ICH4016-5mg | Alirocumab Biosimilar – Research Grade | 5mg |
| 1349 | ICH4017-100mg | Avelumab Biosimilar – Research Grade | 100mg |
| 1350 | ICH4017-10mg | Avelumab Biosimilar – Research Grade | 10mg |
| 1351 | ICH4017-1mg | Avelumab Biosimilar – Research Grade | 1mg |
| 1352 | ICH4017-20mg | Avelumab Biosimilar – Research Grade | 20mg |
| 1353 | ICH4017-50mg | Avelumab Biosimilar – Research Grade | 50mg |
| 1354 | ICH4017-5mg | Avelumab Biosimilar – Research Grade | 5mg |
| 1355 | ICH4018-100mg | Atezolizumab Biosimilar – Research Grade | 100mg |
| 1356 | ICH4018-10mg | Atezolizumab Biosimilar – Research Grade | 10mg |
| 1357 | ICH4018-1mg | Atezolizumab Biosimilar – Research Grade | 1mg |
| 1358 | ICH4018-20mg | Atezolizumab Biosimilar – Research Grade | 20mg |
| 1359 | ICH4018-50mg | Atezolizumab Biosimilar – Research Grade | 50mg |
| 1360 | ICH4018-5mg | Atezolizumab Biosimilar – Research Grade | 5mg |
| 1361 | ICH4018APC-50ug | Atezolizumab Biosimilar – Research Grade: APC | 50ug |
| 1362 | ICH4018D488-0.1mg | Atezolizumab Biosimilar – Dylight488 Research Grade | 100ug |
| 1363 | ICH4018PE-50ug | Atezolizumab Biosimilar – PE Research Grade | 50ug |
| 1364 | ICH4019-100mg | Denosumab Biosimilar – Research Grade | 100mg |
| 1365 | ICH4019-10mg | Denosumab Biosimilar – Research Grade | 10mg |
| 1366 | ICH4019-1mg | Denosumab Biosimilar – Research Grade | 1mg |
| 1367 | ICH4019-20mg | Denosumab Biosimilar – Research Grade | 20mg |
| 1368 | ICH4019-50mg | Denosumab Biosimilar – Research Grade | 50mg |
| 1369 | ICH4019-5mg | Denosumab Biosimilar – Research Grade | 5mg |
| 1370 | ICH4020-0.1mg | Daratumumab Biosimilar – Research Grade | 0.1mg |
| 1371 | ICH4020-10mg | Daratumumab Biosimilar – Research Grade | 10mg |
| 1372 | ICH4020-2mg | Daratumumab Biosimilar – Research Grade | 2mg |
| 1373 | ICH4022-100mg | Etanercept Biosimilar – Research Grade | 100mg |
| 1374 | ICH4022-10mg | Etanercept Biosimilar – Research Grade | 10mg |
| 1375 | ICH4022-1mg | Etanercept Biosimilar – Research Grade | 1mg |
| 1376 | ICH4022-20mg | Etanercept Biosimilar – Research Grade | 20mg |
| 1377 | ICH4022-50mg | Etanercept Biosimilar – Research Grade | 50mg |
| 1378 | ICH4022-5mg | Etanercept Biosimilar – Research Grade | 5mg |
| 1379 | ICH4023-100mg | Evolocumab Biosimilar – Research Grade | 100mg |
| 1380 | ICH4023-10mg | Evolocumab Biosimilar – Research Grade | 10mg |
| 1381 | ICH4023-1mg | Evolocumab Biosimilar – Research Grade | 1mg |
| 1382 | ICH4023-20mg | Evolocumab Biosimilar – Research Grade | 20mg |
| 1383 | ICH4023-50mg | Evolocumab Biosimilar – Research Grade | 50mg |
| 1384 | ICH4023-5mg | Evolocumab Biosimilar – Research Grade | 5mg |
| 1385 | ICH4025-100mg | Ipilimumab Biosimilar – Research Grade | 100mg |
| 1386 | ICH4025-10mg | Ipilimumab Biosimilar – Research Grade | 10mg |
| 1387 | ICH4025-1mg | Ipilimumab Biosimilar – Research Grade | 1mg |
| 1388 | ICH4025-20mg | Ipilimumab Biosimilar – Research Grade | 20mg |
| 1389 | ICH4025-50mg | Ipilimumab Biosimilar – Research Grade | 50mg |
| 1390 | ICH4025-5mg | Ipilimumab Biosimilar – Research Grade | 5mg |
| 1391 | ICH4025B-0.1mg | Ipilimumab Biosimilar – Biotin Research Grade | 100ug |
| 1392 | ICH4025HRP-0.1mg | Ipilimumab Biosimilar – HRP Research Grade | 100ug |
| 1393 | ICH4026-100mg | Obinutuzumab Biosimilar – Research Grade | 100mg |
| 1394 | ICH4026-10mg | Obinutuzumab Biosimilar – Research Grade | 10mg |
| 1395 | ICH4026-1mg | Obinutuzumab Biosimilar – Research Grade | 1mg |
| 1396 | ICH4026-20mg | Obinutuzumab Biosimilar – Research Grade | 20mg |
| 1397 | ICH4026-50mg | Obinutuzumab Biosimilar – Research Grade | 50mg |
| 1398 | ICH4026-5mg | Obinutuzumab Biosimilar – Research Grade | 5mg |
| 1399 | ICH4027-100mg | Ofatumumab Biosimilar – Research Grade | 100mg |
| 1400 | ICH4027-10mg | Ofatumumab Biosimilar – Research Grade | 10mg |
| 1401 | ICH4027-1mg | Ofatumumab Biosimilar – Research Grade | 1mg |
| 1402 | ICH4027-20mg | Ofatumumab Biosimilar – Research Grade | 20mg |
| 1403 | ICH4027-50mg | Ofatumumab Biosimilar – Research Grade | 50mg |
| 1404 | ICH4027-5mg | Ofatumumab Biosimilar – Research Grade | 5mg |
| 1405 | ICH4028-100mg | Panitumumab Biosimilar – Research Grade | 100mg |
| 1406 | ICH4028-10mg | Panitumumab Biosimilar – Research Grade | 10mg |
| 1407 | ICH4028-1mg | Panitumumab Biosimilar – Research Grade | 1mg |
| 1408 | ICH4028-20mg | Panitumumab Biosimilar – Research Grade | 20mg |
| 1409 | ICH4028-50mg | Panitumumab Biosimilar – Research Grade | 50mg |
| 1410 | ICH4028-5mg | Panitumumab Biosimilar – Research Grade | 5mg |
| 1411 | ICH4029-100mg | Pembrolizumab Biosimilar – Research Grade | 100mg |
| 1412 | ICH4029-10mg | Pembrolizumab Biosimilar – Research Grade | 10mg |
| 1413 | ICH4029-1mg | Pembrolizumab Biosimilar – Research Grade | 1mg |
| 1414 | ICH4029-20mg | Pembrolizumab Biosimilar – Research Grade | 20mg |
| 1415 | ICH4029-50mg | Pembrolizumab Biosimilar – Research Grade | 50mg |
| 1416 | ICH4029-5mg | Pembrolizumab Biosimilar – Research Grade | 5mg |
| 1417 | ICH4030-100mg | Pertuzumab Biosimilar – Research Grade | 100mg |
| 1418 | ICH4030-10mg | Pertuzumab Biosimilar – Research Grade | 10mg |
| 1419 | ICH4030-1mg | Pertuzumab Biosimilar – Research Grade | 1mg |
| 1420 | ICH4030-20mg | Pertuzumab Biosimilar – Research Grade | 20mg |
| 1421 | ICH4030-50mg | Pertuzumab Biosimilar – Research Grade | 50mg |
| 1422 | ICH4030-5mg | Pertuzumab Biosimilar – Research Grade | 5mg |
| 1423 | ICH4031-10mg | Ranibizumab Biosimilar – Research Grade | 10mg |
| 1424 | ICH4031-20mg | Ranibizumab Biosimilar – Research Grade | 20mg |
| 1425 | ICH4031-2mg | Ranibizumab Biosimilar – Research Grade | 2mg |
| 1426 | ICH4031-5mg | Ranibizumab Biosimilar – Research Grade | 5mg |
| 1427 | ICH4032-100mg | Ramucirumab Biosimilar – Research Grade | 100mg |
| 1428 | ICH4032-10mg | Ramucirumab Biosimilar – Research Grade | 10mg |
| 1429 | ICH4032-1mg | Ramucirumab Biosimilar – Research Grade | 1mg |
| 1430 | ICH4032-20mg | Ramucirumab Biosimilar – Research Grade | 20mg |
| 1431 | ICH4032-50mg | Ramucirumab Biosimilar – Research Grade | 50mg |
| 1432 | ICH4032-5mg | Ramucirumab Biosimilar – Research Grade | 5mg |
| 1433 | ICH4033-100mg | Secukinumab Biosimilar – Research Grade | 100mg |
| 1434 | ICH4033-10mg | Secukinumab Biosimilar – Research Grade | 10mg |
| 1435 | ICH4033-1mg | Secukinumab Biosimilar – Research Grade | 1mg |
| 1436 | ICH4033-20mg | Secukinumab Biosimilar – Research Grade | 20mg |
| 1437 | ICH4033-50mg | Secukinumab Biosimilar – Research Grade | 50mg |
| 1438 | ICH4033-5mg | Secukinumab Biosimilar – Research Grade | 5mg |
| 1439 | ICH4034-100mg | Ustekinumab Biosimilar – Research Grade | 100mg |
| 1440 | ICH4034-10mg | Ustekinumab Biosimilar – Research Grade | 10mg |
| 1441 | ICH4034-1mg | Ustekinumab Biosimilar – Research Grade | 1mg |
| 1442 | ICH4034-20mg | Ustekinumab Biosimilar – Research Grade | 20mg |
| 1443 | ICH4034-50mg | Ustekinumab Biosimilar – Research Grade | 50mg |
| 1444 | ICH4034-5mg | Ustekinumab Biosimilar – Research Grade | 5mg |
| 1445 | ICH4035-100mg | Vedolizumab Biosimilar – Research Grade | 100mg |
| 1446 | ICH4035-10mg | Vedolizumab Biosimilar – Research Grade | 10mg |
| 1447 | ICH4035-1mg | Vedolizumab Biosimilar – Research Grade | 1mg |
| 1448 | ICH4035-20mg | Vedolizumab Biosimilar – Research Grade | 20mg |
| 1449 | ICH4035-50mg | Vedolizumab Biosimilar – Research Grade | 50mg |
| 1450 | ICH4035-5mg | Vedolizumab Biosimilar – Research Grade | 5mg |
| 1451 | ICH4037-100mg | Natalizumab Biosimilar – Research Grade | 100mg |
| 1452 | ICH4037-10mg | Natalizumab Biosimilar – Research Grade | 10mg |
| 1453 | ICH4037-1mg | Natalizumab Biosimilar – Research Grade | 1mg |
| 1454 | ICH4037-20mg | Natalizumab Biosimilar – Research Grade | 20mg |
| 1455 | ICH4037-50mg | Natalizumab Biosimilar – Research Grade | 50mg |
| 1456 | ICH4037-5mg | Natalizumab Biosimilar – Research Grade | 5mg |
| 1457 | ICH4037APC-50ug | Natalizumab Biosimilar – Research Grade: APC | 50ug |
| 1458 | ICH4037D488-0.1mg | Natalizumab Biosimilar – Dylight488 Research Grade | 100ug |
| 1459 | ICH4037PE-50ug | Natalizumab Biosimilar – PE Research Grade | 50ug |
| 1460 | ICH5001-100mg | Sintilimab Biosimilar – Research Grade | 100mg |
| 1461 | ICH5001-10mg | Sintilimab Biosimilar – Research Grade | 10mg |
| 1462 | ICH5001-1mg | Sintilimab Biosimilar – Research Grade | 1mg |
| 1463 | ICH5001-20mg | Sintilimab Biosimilar – Research Grade | 20mg |
| 1464 | ICH5001-50mg | Sintilimab Biosimilar – Research Grade | 50mg |
| 1465 | ICH5001-5mg | Sintilimab Biosimilar – Research Grade | 5mg |
| 1466 | ICH5002-100mg | Toripalimab Biosimilar – Research Grade | 100mg |
| 1467 | ICH5002-10mg | Toripalimab Biosimilar – Research Grade | 10mg |
| 1468 | ICH5002-1mg | Toripalimab Biosimilar – Research Grade | 1mg |
| 1469 | ICH5002-20mg | Toripalimab Biosimilar – Research Grade | 20mg |
| 1470 | ICH5002-50mg | Toripalimab Biosimilar – Research Grade | 50mg |
| 1471 | ICH5002-5mg | Toripalimab Biosimilar – Research Grade | 5mg |
| 1472 | ICH5003-100mg | Camrelizumab Biosimilar – Research Grade | 100mg |
| 1473 | ICH5003-10mg | Camrelizumab Biosimilar – Research Grade | 10mg |
| 1474 | ICH5003-1mg | Camrelizumab Biosimilar – Research Grade | 1mg |
| 1475 | ICH5003-20mg | Camrelizumab Biosimilar – Research Grade | 20mg |
| 1476 | ICH5003-50mg | Camrelizumab Biosimilar – Research Grade | 50mg |
| 1477 | ICH5003-5mg | Camrelizumab Biosimilar – Research Grade | 5mg |
| 1478 | ICH5004-100mg | Tislelizumab Biosimilar – Research Grade | 100mg |
| 1479 | ICH5004-10mg | Tislelizumab Biosimilar – Research Grade | 10mg |
| 1480 | ICH5004-1mg | Tislelizumab Biosimilar – Research Grade | 1mg |
| 1481 | ICH5004-20mg | Tislelizumab Biosimilar – Research Grade | 20mg |
| 1482 | ICH5004-50mg | Tislelizumab Biosimilar – Research Grade | 50mg |
| 1483 | ICH5004-5mg | Tislelizumab Biosimilar – Research Grade | 5mg |
| 1484 | ICH5005-100mg | Durvalumab Biosimilar – Research Grade | 100mg |
| 1485 | ICH5005-10mg | Durvalumab Biosimilar – Research Grade | 10mg |
| 1486 | ICH5005-1mg | Durvalumab Biosimilar – Research Grade | 1mg |
| 1487 | ICH5005-20mg | Durvalumab Biosimilar – Research Grade | 20mg |
| 1488 | ICH5005-50mg | Durvalumab Biosimilar – Research Grade | 50mg |
| 1489 | ICH5005-5mg | Durvalumab Biosimilar – Research Grade | 5mg |
| 1490 | ICH5007-100mg | Naptumomab Biosimilar – Research Grade | 100mg |
| 1491 | ICH5007-10mg | Naptumomab Biosimilar – Research Grade | 10mg |
| 1492 | ICH5007-1mg | Naptumomab Biosimilar – Research Grade | 1mg |
| 1493 | ICH5007-20mg | Naptumomab Biosimilar – Research Grade | 20mg |
| 1494 | ICH5007-50mg | Naptumomab Biosimilar – Research Grade | 50mg |
| 1495 | ICH5007-5mg | Naptumomab Biosimilar – Research Grade | 5mg |
| 1496 | ICH5008-100mg | Aducanumab Biosimilar – Research Grade | 100mg |
| 1497 | ICH5008-10mg | Aducanumab Biosimilar – Research Grade | 10mg |
| 1498 | ICH5008-1mg | Aducanumab Biosimilar – Research Grade | 1mg |
| 1499 | ICH5008-20mg | Aducanumab Biosimilar – Research Grade | 20mg |
| 1500 | ICH5008-50mg | Aducanumab Biosimilar – Research Grade | 50mg |
| 1501 | ICH5008-5mg | Aducanumab Biosimilar – Research Grade | 5mg |
| 1502 | ICH5009-100mg | Gantenerumab Biosimilar – Research Grade | 100mg |
| 1503 | ICH5009-10mg | Gantenerumab Biosimilar – Research Grade | 10mg |
| 1504 | ICH5009-1mg | Gantenerumab Biosimilar – Research Grade | 1mg |
| 1505 | ICH5009-20mg | Gantenerumab Biosimilar – Research Grade | 20mg |
| 1506 | ICH5009-50mg | Gantenerumab Biosimilar – Research Grade | 50mg |
| 1507 | ICH5009-5mg | Gantenerumab Biosimilar – Research Grade | 5mg |
| 1508 | ICH5010-100mg | Nesvacumab Biosimilar – Research Grade | 100mg |
| 1509 | ICH5010-10mg | Nesvacumab Biosimilar – Research Grade | 10mg |
| 1510 | ICH5010-1mg | Nesvacumab Biosimilar – Research Grade | 1mg |
| 1511 | ICH5010-20mg | Nesvacumab Biosimilar – Research Grade | 20mg |
| 1512 | ICH5010-50mg | Nesvacumab Biosimilar – Research Grade | 50mg |
| 1513 | ICH5010-5mg | Nesvacumab Biosimilar – Research Grade | 5mg |
| 1514 | ICH5011-100mg | Belantamab Biosimilar – Research Grade | 100mg |
| 1515 | ICH5011-10mg | Belantamab Biosimilar – Research Grade | 10mg |
| 1516 | ICH5011-1mg | Belantamab Biosimilar – Research Grade | 1mg |
| 1517 | ICH5011-20mg | Belantamab Biosimilar – Research Grade | 20mg |
| 1518 | ICH5011-50mg | Belantamab Biosimilar – Research Grade | 50mg |
| 1519 | ICH5011-5mg | Belantamab Biosimilar – Research Grade | 5mg |
| 1520 | ICH5012-100mg | Sutimlimab Biosimilar – Research Grade | 100mg |
| 1521 | ICH5012-10mg | Sutimlimab Biosimilar – Research Grade | 10mg |
| 1522 | ICH5012-1mg | Sutimlimab Biosimilar – Research Grade | 1mg |
| 1523 | ICH5012-20mg | Sutimlimab Biosimilar – Research Grade | 20mg |
| 1524 | ICH5012-50mg | Sutimlimab Biosimilar – Research Grade | 50mg |
| 1525 | ICH5012-5mg | Sutimlimab Biosimilar – Research Grade | 5mg |
| 1526 | ICH5013-100mg | Girentuximab Biosimilar – Research Grade | 100mg |
| 1527 | ICH5013-10mg | Girentuximab Biosimilar – Research Grade | 10mg |
| 1528 | ICH5013-1mg | Girentuximab Biosimilar – Research Grade | 1mg |
| 1529 | ICH5013-20mg | Girentuximab Biosimilar – Research Grade | 20mg |
| 1530 | ICH5013-50mg | Girentuximab Biosimilar – Research Grade | 50mg |
| 1531 | ICH5013-5mg | Girentuximab Biosimilar – Research Grade | 5mg |
| 1532 | ICH5014-100mg | Utomilumab Biosimilar – Research Grade | 100mg |
| 1533 | ICH5014-10mg | Utomilumab Biosimilar – Research Grade | 10mg |
| 1534 | ICH5014-1mg | Utomilumab Biosimilar – Research Grade | 1mg |
| 1535 | ICH5014-20mg | Utomilumab Biosimilar – Research Grade | 20mg |
| 1536 | ICH5014-50mg | Utomilumab Biosimilar – Research Grade | 50mg |
| 1537 | ICH5014-5mg | Utomilumab Biosimilar – Research Grade | 5mg |
| 1538 | ICH5015-100mg | Urelumab Biosimilar – Research Grade | 100mg |
| 1539 | ICH5015-10mg | Urelumab Biosimilar – Research Grade | 10mg |
| 1540 | ICH5015-1mg | Urelumab Biosimilar – Research Grade | 1mg |
| 1541 | ICH5015-20mg | Urelumab Biosimilar – Research Grade | 20mg |
| 1542 | ICH5015-50mg | Urelumab Biosimilar – Research Grade | 50mg |
| 1543 | ICH5015-5mg | Urelumab Biosimilar – Research Grade | 5mg |
| 1544 | ICH5016-100mg | Atibuclimab Biosimilar – Research Grade | 100mg |
| 1545 | ICH5016-10mg | Atibuclimab Biosimilar – Research Grade | 10mg |
| 1546 | ICH5016-1mg | Atibuclimab Biosimilar – Research Grade | 1mg |
| 1547 | ICH5016-20mg | Atibuclimab Biosimilar – Research Grade | 20mg |
| 1548 | ICH5016-50mg | Atibuclimab Biosimilar – Research Grade | 50mg |
| 1549 | ICH5016-5mg | Atibuclimab Biosimilar – Research Grade | 5mg |
| 1550 | ICH5017-100mg | Monalizumab Biosimilar – Research Grade | 100mg |
| 1551 | ICH5017-10mg | Monalizumab Biosimilar – Research Grade | 10mg |
| 1552 | ICH5017-1mg | Monalizumab Biosimilar – Research Grade | 1mg |
| 1553 | ICH5017-20mg | Monalizumab Biosimilar – Research Grade | 20mg |
| 1554 | ICH5017-50mg | Monalizumab Biosimilar – Research Grade | 50mg |
| 1555 | ICH5017-5mg | Monalizumab Biosimilar – Research Grade | 5mg |
| 1556 | ICH5019-100mg | Glofitamab Biosimilar – Research Grade | 100mg |
| 1557 | ICH5019-10mg | Glofitamab Biosimilar – Research Grade | 10mg |
| 1558 | ICH5019-1mg | Glofitamab Biosimilar – Research Grade | 1mg |
| 1559 | ICH5019-20mg | Glofitamab Biosimilar – Research Grade | 20mg |
| 1560 | ICH5019-50mg | Glofitamab Biosimilar – Research Grade | 50mg |
| 1561 | ICH5019-5mg | Glofitamab Biosimilar – Research Grade | 5mg |
| 1562 | ICH5021-100mg | Daclizumab Biosimilar – Research Grade | 100mg |
| 1563 | ICH5021-10mg | Daclizumab Biosimilar – Research Grade | 10mg |
| 1564 | ICH5021-1mg | Daclizumab Biosimilar – Research Grade | 1mg |
| 1565 | ICH5021-20mg | Daclizumab Biosimilar – Research Grade | 20mg |
| 1566 | ICH5021-50mg | Daclizumab Biosimilar – Research Grade | 50mg |
| 1567 | ICH5021-5mg | Daclizumab Biosimilar – Research Grade | 5mg |
| 1568 | ICH5022-100mg | Varlilumab Biosimilar – Research Grade | 100mg |
| 1569 | ICH5022-10mg | Varlilumab Biosimilar – Research Grade | 10mg |
| 1570 | ICH5022-1mg | Varlilumab Biosimilar – Research Grade | 1mg |
| 1571 | ICH5022-20mg | Varlilumab Biosimilar – Research Grade | 20mg |
| 1572 | ICH5022-50mg | Varlilumab Biosimilar – Research Grade | 50mg |
| 1573 | ICH5022-5mg | Varlilumab Biosimilar – Research Grade | 5mg |
| 1574 | ICH5023-100mg | Theralizumab Biosimilar – Research Grade | 100mg |
| 1575 | ICH5023-10mg | Theralizumab Biosimilar – Research Grade | 10mg |
| 1576 | ICH5023-1mg | Theralizumab Biosimilar – Research Grade | 1mg |
| 1577 | ICH5023-20mg | Theralizumab Biosimilar – Research Grade | 20mg |
| 1578 | ICH5023-50mg | Theralizumab Biosimilar – Research Grade | 50mg |
| 1579 | ICH5023-5mg | Theralizumab Biosimilar – Research Grade | 5mg |
| 1580 | ICH5024-100mg | Muromonab Biosimilar – Research Grade | 100mg |
| 1581 | ICH5024-10mg | Muromonab Biosimilar – Research Grade | 10mg |
| 1582 | ICH5024-1mg | Muromonab Biosimilar – Research Grade | 1mg |
| 1583 | ICH5024-20mg | Muromonab Biosimilar – Research Grade | 20mg |
| 1584 | ICH5024-50mg | Muromonab Biosimilar – Research Grade | 50mg |
| 1585 | ICH5024-5mg | Muromonab Biosimilar – Research Grade | 5mg |
| 1586 | ICH5025-0.1mg | Blinatumomab Biosimilar – Research Grade | 0.1mg |
| 1587 | ICH5025-0.5mg | Blinatumomab Biosimilar – Research Grade | 0.5mg |
| 1588 | ICH5025-1mg | Blinatumomab Biosimilar – Research Grade | 1mg |
| 1589 | ICH5025-5mg | Blinatumomab Biosimilar – Research Grade | 5mg |
| 1590 | ICH5026-100mg | Mosunetuzumab Biosimilar – Research Grade | 100mg |
| 1591 | ICH5026-10mg | Mosunetuzumab Biosimilar – Research Grade | 10mg |
| 1592 | ICH5026-1mg | Mosunetuzumab Biosimilar – Research Grade | 1mg |
| 1593 | ICH5026-20mg | Mosunetuzumab Biosimilar – Research Grade | 20mg |
| 1594 | ICH5026-50mg | Mosunetuzumab Biosimilar – Research Grade | 50mg |
| 1595 | ICH5026-5mg | Mosunetuzumab Biosimilar – Research Grade | 5mg |
| 1596 | ICH5027-100mg | Odronextamab Biosimilar – Research Grade | 100mg |
| 1597 | ICH5027-10mg | Odronextamab Biosimilar – Research Grade | 10mg |
| 1598 | ICH5027-1mg | Odronextamab Biosimilar – Research Grade | 1mg |
| 1599 | ICH5027-20mg | Odronextamab Biosimilar – Research Grade | 20mg |
| 1600 | ICH5027-50mg | Odronextamab Biosimilar – Research Grade | 50mg |
| 1601 | ICH5027-5mg | Odronextamab Biosimilar – Research Grade | 5mg |
| 1602 | ICH5028-100mg | Isatuximab Biosimilar – Research Grade | 100mg |
| 1603 | ICH5028-10mg | Isatuximab Biosimilar – Research Grade | 10mg |
| 1604 | ICH5028-1mg | Isatuximab Biosimilar – Research Grade | 1mg |
| 1605 | ICH5028-20mg | Isatuximab Biosimilar – Research Grade | 20mg |
| 1606 | ICH5028-50mg | Isatuximab Biosimilar – Research Grade | 50mg |
| 1607 | ICH5028-5mg | Isatuximab Biosimilar – Research Grade | 5mg |
| 1608 | ICH5029-100mg | Ibalizumab Biosimilar – Research Grade | 100mg |
| 1609 | ICH5029-10mg | Ibalizumab Biosimilar – Research Grade | 10mg |
| 1610 | ICH5029-1mg | Ibalizumab Biosimilar – Research Grade | 1mg |
| 1611 | ICH5029-20mg | Ibalizumab Biosimilar – Research Grade | 20mg |
| 1612 | ICH5029-50mg | Ibalizumab Biosimilar – Research Grade | 50mg |
| 1613 | ICH5029-5mg | Ibalizumab Biosimilar – Research Grade | 5mg |
| 1614 | ICH5030-100mg | Dacetuzumab Biosimilar – Research Grade | 100mg |
| 1615 | ICH5030-10mg | Dacetuzumab Biosimilar – Research Grade | 10mg |
| 1616 | ICH5030-1mg | Dacetuzumab Biosimilar – Research Grade | 1mg |
| 1617 | ICH5030-20mg | Dacetuzumab Biosimilar – Research Grade | 20mg |
| 1618 | ICH5030-50mg | Dacetuzumab Biosimilar – Research Grade | 50mg |
| 1619 | ICH5030-5mg | Dacetuzumab Biosimilar – Research Grade | 5mg |
| 1620 | ICH5031-100mg | Sotigalimab Biosimilar – Research Grade | 100mg |
| 1621 | ICH5031-10mg | Sotigalimab Biosimilar – Research Grade | 10mg |
| 1622 | ICH5031-1mg | Sotigalimab Biosimilar – Research Grade | 1mg |
| 1623 | ICH5031-20mg | Sotigalimab Biosimilar – Research Grade | 20mg |
| 1624 | ICH5031-50mg | Sotigalimab Biosimilar – Research Grade | 50mg |
| 1625 | ICH5031-5mg | Sotigalimab Biosimilar – Research Grade | 5mg |
| 1626 | ICH5032-100mg | Selicrelumab Biosimilar – Research Grade | 100mg |
| 1627 | ICH5032-10mg | Selicrelumab Biosimilar – Research Grade | 10mg |
| 1628 | ICH5032-1mg | Selicrelumab Biosimilar – Research Grade | 1mg |
| 1629 | ICH5032-20mg | Selicrelumab Biosimilar – Research Grade | 20mg |
| 1630 | ICH5032-50mg | Selicrelumab Biosimilar – Research Grade | 50mg |
| 1631 | ICH5032-5mg | Selicrelumab Biosimilar – Research Grade | 5mg |
| 1632 | ICH5034-100mg | Lemzoparlimab Biosimilar – Research Grade | 100mg |
| 1633 | ICH5034-10mg | Lemzoparlimab Biosimilar – Research Grade | 10mg |
| 1634 | ICH5034-1mg | Lemzoparlimab Biosimilar – Research Grade | 1mg |
| 1635 | ICH5034-20mg | Lemzoparlimab Biosimilar – Research Grade | 20mg |
| 1636 | ICH5034-50mg | Lemzoparlimab Biosimilar – Research Grade | 50mg |
| 1637 | ICH5034-5mg | Lemzoparlimab Biosimilar – Research Grade | 5mg |
| 1638 | ICH5036-100mg | Magrolimab Biosimilar – Research Grade | 100mg |
| 1639 | ICH5036-10mg | Magrolimab Biosimilar – Research Grade | 10mg |
| 1640 | ICH5036-1mg | Magrolimab Biosimilar – Research Grade | 1mg |
| 1641 | ICH5036-20mg | Magrolimab Biosimilar – Research Grade | 20mg |
| 1642 | ICH5036-50mg | Magrolimab Biosimilar – Research Grade | 50mg |
| 1643 | ICH5036-5mg | Magrolimab Biosimilar – Research Grade | 5mg |
| 1644 | ICH5037-100mg | Cusatuzumab Biosimilar – Research Grade | 100mg |
| 1645 | ICH5037-10mg | Cusatuzumab Biosimilar – Research Grade | 10mg |
| 1646 | ICH5037-1mg | Cusatuzumab Biosimilar – Research Grade | 1mg |
| 1647 | ICH5037-20mg | Cusatuzumab Biosimilar – Research Grade | 20mg |
| 1648 | ICH5037-50mg | Cusatuzumab Biosimilar – Research Grade | 50mg |
| 1649 | ICH5037-5mg | Cusatuzumab Biosimilar – Research Grade | 5mg |
| 1650 | ICH5038-100mg | Oleclumab Biosimilar – Research Grade | 100mg |
| 1651 | ICH5038-10mg | Oleclumab Biosimilar – Research Grade | 10mg |
| 1652 | ICH5038-1mg | Oleclumab Biosimilar – Research Grade | 1mg |
| 1653 | ICH5038-20mg | Oleclumab Biosimilar – Research Grade | 20mg |
| 1654 | ICH5038-50mg | Oleclumab Biosimilar – Research Grade | 50mg |
| 1655 | ICH5038-5mg | Oleclumab Biosimilar – Research Grade | 5mg |
| 1656 | ICH5039-100mg | Polatuzumab Biosimilar – Research Grade | 100mg |
| 1657 | ICH5039-10mg | Polatuzumab Biosimilar – Research Grade | 10mg |
| 1658 | ICH5039-1mg | Polatuzumab Biosimilar – Research Grade | 1mg |
| 1659 | ICH5039-20mg | Polatuzumab Biosimilar – Research Grade | 20mg |
| 1660 | ICH5039-50mg | Polatuzumab Biosimilar – Research Grade | 50mg |
| 1661 | ICH5039-5mg | Polatuzumab Biosimilar – Research Grade | 5mg |
| 1662 | ICH5040-100mg | Tusamitamab Biosimilar – Research Grade | 100mg |
| 1663 | ICH5040-10mg | Tusamitamab Biosimilar – Research Grade | 10mg |
| 1664 | ICH5040-1mg | Tusamitamab Biosimilar – Research Grade | 1mg |
| 1665 | ICH5040-20mg | Tusamitamab Biosimilar – Research Grade | 20mg |
| 1666 | ICH5040-50mg | Tusamitamab Biosimilar – Research Grade | 50mg |
| 1667 | ICH5040-5mg | Tusamitamab Biosimilar – Research Grade | 5mg |
| 1668 | ICH5041-100mg | Cibisatamab Biosimilar – Research Grade | 100mg |
| 1669 | ICH5041-10mg | Cibisatamab Biosimilar – Research Grade | 10mg |
| 1670 | ICH5041-1mg | Cibisatamab Biosimilar – Research Grade | 1mg |
| 1671 | ICH5041-20mg | Cibisatamab Biosimilar – Research Grade | 20mg |
| 1672 | ICH5041-50mg | Cibisatamab Biosimilar – Research Grade | 50mg |
| 1673 | ICH5041-5mg | Cibisatamab Biosimilar – Research Grade | 5mg |
| 1674 | ICH5042-100mg | Tinurilimab Biosimilar – Research Grade | 100mg |
| 1675 | ICH5042-10mg | Tinurilimab Biosimilar – Research Grade | 10mg |
| 1676 | ICH5042-1mg | Tinurilimab Biosimilar – Research Grade | 1mg |
| 1677 | ICH5042-20mg | Tinurilimab Biosimilar – Research Grade | 20mg |
| 1678 | ICH5042-50mg | Tinurilimab Biosimilar – Research Grade | 50mg |
| 1679 | ICH5042-5mg | Tinurilimab Biosimilar – Research Grade | 5mg |
| 1680 | ICH5043-100mg | Erenumab Biosimilar – Research Grade | 100mg |
| 1681 | ICH5043-10mg | Erenumab Biosimilar – Research Grade | 10mg |
| 1682 | ICH5043-1mg | Erenumab Biosimilar – Research Grade | 1mg |
| 1683 | ICH5043-20mg | Erenumab Biosimilar – Research Grade | 20mg |
| 1684 | ICH5043-50mg | Erenumab Biosimilar – Research Grade | 50mg |
| 1685 | ICH5043-5mg | Erenumab Biosimilar – Research Grade | 5mg |
| 1686 | ICH5044-100mg | Eptinezumab Biosimilar – Research Grade | 100mg |
| 1687 | ICH5044-10mg | Eptinezumab Biosimilar – Research Grade | 10mg |
| 1688 | ICH5044-1mg | Eptinezumab Biosimilar – Research Grade | 1mg |
| 1689 | ICH5044-20mg | Eptinezumab Biosimilar – Research Grade | 20mg |
| 1690 | ICH5044-50mg | Eptinezumab Biosimilar – Research Grade | 50mg |
| 1691 | ICH5044-5mg | Eptinezumab Biosimilar – Research Grade | 5mg |
| 1692 | ICH5045-100mg | Fremanezumab Biosimilar – Research Grade | 100mg |
| 1693 | ICH5045-10mg | Fremanezumab Biosimilar – Research Grade | 10mg |
| 1694 | ICH5045-1mg | Fremanezumab Biosimilar – Research Grade | 1mg |
| 1695 | ICH5045-20mg | Fremanezumab Biosimilar – Research Grade | 20mg |
| 1696 | ICH5045-50mg | Fremanezumab Biosimilar – Research Grade | 50mg |
| 1697 | ICH5045-5mg | Fremanezumab Biosimilar – Research Grade | 5mg |
| 1698 | ICH5046-100mg | Galcanezumab Biosimilar – Research Grade | 100mg |
| 1699 | ICH5046-10mg | Galcanezumab Biosimilar – Research Grade | 10mg |
| 1700 | ICH5046-1mg | Galcanezumab Biosimilar – Research Grade | 1mg |
| 1701 | ICH5046-20mg | Galcanezumab Biosimilar – Research Grade | 20mg |
| 1702 | ICH5046-50mg | Galcanezumab Biosimilar – Research Grade | 50mg |
| 1703 | ICH5046-5mg | Galcanezumab Biosimilar – Research Grade | 5mg |
| 1704 | ICH5047-100mg | Zolbetuximab Biosimilar – Research Grade | 100mg |
| 1705 | ICH5047-10mg | Zolbetuximab Biosimilar – Research Grade | 10mg |
| 1706 | ICH5047-1mg | Zolbetuximab Biosimilar – Research Grade | 1mg |
| 1707 | ICH5047-20mg | Zolbetuximab Biosimilar – Research Grade | 20mg |
| 1708 | ICH5047-50mg | Zolbetuximab Biosimilar – Research Grade | 50mg |
| 1709 | ICH5047-5mg | Zolbetuximab Biosimilar – Research Grade | 5mg |
| 1710 | ICH5048-100mg | Rovalpituzumab Biosimilar – Research Grade | 100mg |
| 1711 | ICH5048-10mg | Rovalpituzumab Biosimilar – Research Grade | 10mg |
| 1712 | ICH5048-1mg | Rovalpituzumab Biosimilar – Research Grade | 1mg |
| 1713 | ICH5048-20mg | Rovalpituzumab Biosimilar – Research Grade | 20mg |
| 1714 | ICH5048-50mg | Rovalpituzumab Biosimilar – Research Grade | 50mg |
| 1715 | ICH5048-5mg | Rovalpituzumab Biosimilar – Research Grade | 5mg |
| 1716 | ICH5049-100mg | Batoclimab Biosimilar – Research Grade | 100mg |
| 1717 | ICH5049-10mg | Batoclimab Biosimilar – Research Grade | 10mg |
| 1718 | ICH5049-1mg | Batoclimab Biosimilar – Research Grade | 1mg |
| 1719 | ICH5049-20mg | Batoclimab Biosimilar – Research Grade | 20mg |
| 1720 | ICH5049-50mg | Batoclimab Biosimilar – Research Grade | 50mg |
| 1721 | ICH5049-5mg | Batoclimab Biosimilar – Research Grade | 5mg |
| 1722 | ICH5050-100mg | Nipocalimab Biosimilar – Research Grade | 100mg |
| 1723 | ICH5050-10mg | Nipocalimab Biosimilar – Research Grade | 10mg |
| 1724 | ICH5050-1mg | Nipocalimab Biosimilar – Research Grade | 1mg |
| 1725 | ICH5050-20mg | Nipocalimab Biosimilar – Research Grade | 20mg |
| 1726 | ICH5050-50mg | Nipocalimab Biosimilar – Research Grade | 50mg |
| 1727 | ICH5050-5mg | Nipocalimab Biosimilar – Research Grade | 5mg |
| 1728 | ICH5051-100mg | Rozanolixizumab Biosimilar – Research Grade | 100mg |
| 1729 | ICH5051-10mg | Rozanolixizumab Biosimilar – Research Grade | 10mg |
| 1730 | ICH5051-1mg | Rozanolixizumab Biosimilar – Research Grade | 1mg |
| 1731 | ICH5051-20mg | Rozanolixizumab Biosimilar – Research Grade | 20mg |
| 1732 | ICH5051-50mg | Rozanolixizumab Biosimilar – Research Grade | 50mg |
| 1733 | ICH5051-5mg | Rozanolixizumab Biosimilar – Research Grade | 5mg |
| 1734 | ICH5052-100mg | Aprutumab Biosimilar – Research Grade | 100mg |
| 1735 | ICH5052-10mg | Aprutumab Biosimilar – Research Grade | 10mg |
| 1736 | ICH5052-1mg | Aprutumab Biosimilar – Research Grade | 1mg |
| 1737 | ICH5052-20mg | Aprutumab Biosimilar – Research Grade | 20mg |
| 1738 | ICH5052-50mg | Aprutumab Biosimilar – Research Grade | 50mg |
| 1739 | ICH5052-5mg | Aprutumab Biosimilar – Research Grade | 5mg |
| 1740 | ICH5053-100mg | Bemarituzumab Biosimilar – Research Grade | 100mg |
| 1741 | ICH5053-10mg | Bemarituzumab Biosimilar – Research Grade | 10mg |
| 1742 | ICH5053-1mg | Bemarituzumab Biosimilar – Research Grade | 1mg |
| 1743 | ICH5053-20mg | Bemarituzumab Biosimilar – Research Grade | 20mg |
| 1744 | ICH5053-50mg | Bemarituzumab Biosimilar – Research Grade | 50mg |
| 1745 | ICH5053-5mg | Bemarituzumab Biosimilar – Research Grade | 5mg |
| 1746 | ICH5054-100mg | Mavrilimumab Biosimilar – Research Grade | 100mg |
| 1747 | ICH5054-10mg | Mavrilimumab Biosimilar – Research Grade | 10mg |
| 1748 | ICH5054-1mg | Mavrilimumab Biosimilar – Research Grade | 1mg |
| 1749 | ICH5054-20mg | Mavrilimumab Biosimilar – Research Grade | 20mg |
| 1750 | ICH5054-50mg | Mavrilimumab Biosimilar – Research Grade | 50mg |
| 1751 | ICH5054-5mg | Mavrilimumab Biosimilar – Research Grade | 5mg |
| 1752 | ICH5055-100mg | Codrituzumab Biosimilar – Research Grade | 100mg |
| 1753 | ICH5055-10mg | Codrituzumab Biosimilar – Research Grade | 10mg |
| 1754 | ICH5055-1mg | Codrituzumab Biosimilar – Research Grade | 1mg |
| 1755 | ICH5055-20mg | Codrituzumab Biosimilar – Research Grade | 20mg |
| 1756 | ICH5055-50mg | Codrituzumab Biosimilar – Research Grade | 50mg |
| 1757 | ICH5055-5mg | Codrituzumab Biosimilar – Research Grade | 5mg |
| 1758 | ICH5056-100mg | Abciximab Biosimilar – Research Grade | 100mg |
| 1759 | ICH5056-10mg | Abciximab Biosimilar – Research Grade | 10mg |
| 1760 | ICH5056-1mg | Abciximab Biosimilar – Research Grade | 1mg |
| 1761 | ICH5056-20mg | Abciximab Biosimilar – Research Grade | 20mg |
| 1762 | ICH5056-50mg | Abciximab Biosimilar – Research Grade | 50mg |
| 1763 | ICH5056-5mg | Abciximab Biosimilar – Research Grade | 5mg |
| 1764 | ICH5057-100mg | Margetuximab Biosimilar – Research Grade | 100mg |
| 1765 | ICH5057-10mg | Margetuximab Biosimilar – Research Grade | 10mg |
| 1766 | ICH5057-1mg | Margetuximab Biosimilar – Research Grade | 1mg |
| 1767 | ICH5057-20mg | Margetuximab Biosimilar – Research Grade | 20mg |
| 1768 | ICH5057-50mg | Margetuximab Biosimilar – Research Grade | 50mg |
| 1769 | ICH5057-5mg | Margetuximab Biosimilar – Research Grade | 5mg |
| 1770 | ICH5058-100mg | Lebrikizumab Biosimilar – Research Grade | 100mg |
| 1771 | ICH5058-10mg | Lebrikizumab Biosimilar – Research Grade | 10mg |
| 1772 | ICH5058-1mg | Lebrikizumab Biosimilar – Research Grade | 1mg |
| 1773 | ICH5058-20mg | Lebrikizumab Biosimilar – Research Grade | 20mg |
| 1774 | ICH5058-50mg | Lebrikizumab Biosimilar – Research Grade | 50mg |
| 1775 | ICH5058-5mg | Lebrikizumab Biosimilar – Research Grade | 5mg |
| 1776 | ICH5059-100mg | Tralokinumab Biosimilar – Research Grade | 100mg |
| 1777 | ICH5059-10mg | Tralokinumab Biosimilar – Research Grade | 10mg |
| 1778 | ICH5059-1mg | Tralokinumab Biosimilar – Research Grade | 1mg |
| 1779 | ICH5059-20mg | Tralokinumab Biosimilar – Research Grade | 20mg |
| 1780 | ICH5059-50mg | Tralokinumab Biosimilar – Research Grade | 50mg |
| 1781 | ICH5059-5mg | Tralokinumab Biosimilar – Research Grade | 5mg |
| 1782 | ICH5060-100mg | Brodalumab Biosimilar – Research Grade | 100mg |
| 1783 | ICH5060-10mg | Brodalumab Biosimilar – Research Grade | 10mg |
| 1784 | ICH5060-1mg | Brodalumab Biosimilar – Research Grade | 1mg |
| 1785 | ICH5060-20mg | Brodalumab Biosimilar – Research Grade | 20mg |
| 1786 | ICH5060-50mg | Brodalumab Biosimilar – Research Grade | 50mg |
| 1787 | ICH5060-5mg | Brodalumab Biosimilar – Research Grade | 5mg |
| 1788 | ICH5061-100mg | Etokimab Biosimilar – Research Grade | 100mg |
| 1789 | ICH5061-10mg | Etokimab Biosimilar – Research Grade | 10mg |
| 1790 | ICH5061-1mg | Etokimab Biosimilar – Research Grade | 1mg |
| 1791 | ICH5061-20mg | Etokimab Biosimilar – Research Grade | 20mg |
| 1792 | ICH5061-50mg | Etokimab Biosimilar – Research Grade | 50mg |
| 1793 | ICH5061-5mg | Etokimab Biosimilar – Research Grade | 5mg |
| 1794 | ICH5062-100mg | Dupilumab Biosimilar – Research Grade | 100mg |
| 1795 | ICH5062-10mg | Dupilumab Biosimilar – Research Grade | 10mg |
| 1796 | ICH5062-1mg | Dupilumab Biosimilar – Research Grade | 1mg |
| 1797 | ICH5062-20mg | Dupilumab Biosimilar – Research Grade | 20mg |
| 1798 | ICH5062-50mg | Dupilumab Biosimilar – Research Grade | 50mg |
| 1799 | ICH5062-5mg | Dupilumab Biosimilar – Research Grade | 5mg |
| 1800 | ICH5063-100mg | Clazakizumab Biosimilar – Research Grade | 100mg |
| 1801 | ICH5063-10mg | Clazakizumab Biosimilar – Research Grade | 10mg |
| 1802 | ICH5063-1mg | Clazakizumab Biosimilar – Research Grade | 1mg |
| 1803 | ICH5063-20mg | Clazakizumab Biosimilar – Research Grade | 20mg |
| 1804 | ICH5063-50mg | Clazakizumab Biosimilar – Research Grade | 50mg |
| 1805 | ICH5063-5mg | Clazakizumab Biosimilar – Research Grade | 5mg |
| 1806 | ICH5064-100mg | Guselkumab Biosimilar – Research Grade | 100mg |
| 1807 | ICH5064-10mg | Guselkumab Biosimilar – Research Grade | 10mg |
| 1808 | ICH5064-1mg | Guselkumab Biosimilar – Research Grade | 1mg |
| 1809 | ICH5064-20mg | Guselkumab Biosimilar – Research Grade | 20mg |
| 1810 | ICH5064-50mg | Guselkumab Biosimilar – Research Grade | 50mg |
| 1811 | ICH5064-5mg | Guselkumab Biosimilar – Research Grade | 5mg |
| 1812 | ICH5067-100mg | TSR-033 Biosimilar – Research Grade | 100mg |
| 1813 | ICH5067-10mg | TSR-033 Biosimilar – Research Grade | 10mg |
| 1814 | ICH5067-1mg | TSR-033 Biosimilar – Research Grade | 1mg |
| 1815 | ICH5067-20mg | TSR-033 Biosimilar – Research Grade | 20mg |
| 1816 | ICH5067-50mg | TSR-033 Biosimilar – Research Grade | 50mg |
| 1817 | ICH5067-5mg | TSR-033 Biosimilar – Research Grade | 5mg |
| 1818 | ICH5068-100mg | Simtuzumab Biosimilar – Research Grade | 100mg |
| 1819 | ICH5068-10mg | Simtuzumab Biosimilar – Research Grade | 10mg |
| 1820 | ICH5068-1mg | Simtuzumab Biosimilar – Research Grade | 1mg |
| 1821 | ICH5068-20mg | Simtuzumab Biosimilar – Research Grade | 20mg |
| 1822 | ICH5068-50mg | Simtuzumab Biosimilar – Research Grade | 50mg |
| 1823 | ICH5068-5mg | Simtuzumab Biosimilar – Research Grade | 5mg |
| 1824 | ICH5069-100mg | Amatuximab Biosimilar – Research Grade | 100mg |
| 1825 | ICH5069-10mg | Amatuximab Biosimilar – Research Grade | 10mg |
| 1826 | ICH5069-1mg | Amatuximab Biosimilar – Research Grade | 1mg |
| 1827 | ICH5069-20mg | Amatuximab Biosimilar – Research Grade | 20mg |
| 1828 | ICH5069-50mg | Amatuximab Biosimilar – Research Grade | 50mg |
| 1829 | ICH5069-5mg | Amatuximab Biosimilar – Research Grade | 5mg |
| 1830 | ICH5070-100mg | Enfortumab Biosimilar – Research Grade | 100mg |
| 1831 | ICH5070-10mg | Enfortumab Biosimilar – Research Grade | 10mg |
| 1832 | ICH5070-1mg | Enfortumab Biosimilar – Research Grade | 1mg |
| 1833 | ICH5070-20mg | Enfortumab Biosimilar – Research Grade | 20mg |
| 1834 | ICH5070-50mg | Enfortumab Biosimilar – Research Grade | 50mg |
| 1835 | ICH5070-5mg | Enfortumab Biosimilar – Research Grade | 5mg |
| 1836 | ICH5071-100mg | Palivizumab Biosimilar – Research Grade | 100mg |
| 1837 | ICH5071-10mg | Palivizumab Biosimilar – Research Grade | 10mg |
| 1838 | ICH5071-1mg | Palivizumab Biosimilar – Research Grade | 1mg |
| 1839 | ICH5071-20mg | Palivizumab Biosimilar – Research Grade | 20mg |
| 1840 | ICH5071-50mg | Palivizumab Biosimilar – Research Grade | 50mg |
| 1841 | ICH5071-5mg | Palivizumab Biosimilar – Research Grade | 5mg |
| 1842 | ICH5073-100mg | Gemtuzumab Biosimilar – Research Grade | 100mg |
| 1843 | ICH5073-10mg | Gemtuzumab Biosimilar – Research Grade | 10mg |
| 1844 | ICH5073-1mg | Gemtuzumab Biosimilar – Research Grade | 1mg |
| 1845 | ICH5073-20mg | Gemtuzumab Biosimilar – Research Grade | 20mg |
| 1846 | ICH5073-50mg | Gemtuzumab Biosimilar – Research Grade | 50mg |
| 1847 | ICH5073-5mg | Gemtuzumab Biosimilar – Research Grade | 5mg |
| 1848 | ICH5076-100mg | Sacituzumab Biosimilar – Research Grade | 100mg |
| 1849 | ICH5076-10mg | Sacituzumab Biosimilar – Research Grade | 10mg |
| 1850 | ICH5076-1mg | Sacituzumab Biosimilar – Research Grade | 1mg |
| 1851 | ICH5076-20mg | Sacituzumab Biosimilar – Research Grade | 20mg |
| 1852 | ICH5076-50mg | Sacituzumab Biosimilar – Research Grade | 50mg |
| 1853 | ICH5076-5mg | Sacituzumab Biosimilar – Research Grade | 5mg |
| 1854 | ICH5077-100mg | Fresolimumab Biosimilar – Research Grade | 100mg |
| 1855 | ICH5077-10mg | Fresolimumab Biosimilar – Research Grade | 10mg |
| 1856 | ICH5077-1mg | Fresolimumab Biosimilar – Research Grade | 1mg |
| 1857 | ICH5077-20mg | Fresolimumab Biosimilar – Research Grade | 20mg |
| 1858 | ICH5077-50mg | Fresolimumab Biosimilar – Research Grade | 50mg |
| 1859 | ICH5077-5mg | Fresolimumab Biosimilar – Research Grade | 5mg |
| 1860 | ICH5078-100mg | Tiragolumab Biosimilar – Research Grade | 100mg |
| 1861 | ICH5078-10mg | Tiragolumab Biosimilar – Research Grade | 10mg |
| 1862 | ICH5078-1mg | Tiragolumab Biosimilar – Research Grade | 1mg |
| 1863 | ICH5078-20mg | Tiragolumab Biosimilar – Research Grade | 20mg |
| 1864 | ICH5078-50mg | Tiragolumab Biosimilar – Research Grade | 50mg |
| 1865 | ICH5078-5mg | Tiragolumab Biosimilar – Research Grade | 5mg |
| 1866 | ICH5079-100mg | Sabatolimab Biosimilar – Research Grade | 100mg |
| 1867 | ICH5079-10mg | Sabatolimab Biosimilar – Research Grade | 10mg |
| 1868 | ICH5079-1mg | Sabatolimab Biosimilar – Research Grade | 1mg |
| 1869 | ICH5079-20mg | Sabatolimab Biosimilar – Research Grade | 20mg |
| 1870 | ICH5079-50mg | Sabatolimab Biosimilar – Research Grade | 50mg |
| 1871 | ICH5079-5mg | Sabatolimab Biosimilar – Research Grade | 5mg |
| 1872 | ICH5080-100mg | Belimumab Biosimilar – Research Grade | 100mg |
| 1873 | ICH5080-10mg | Belimumab Biosimilar – Research Grade | 10mg |
| 1874 | ICH5080-1mg | Belimumab Biosimilar – Research Grade | 1mg |
| 1875 | ICH5080-20mg | Belimumab Biosimilar – Research Grade | 20mg |
| 1876 | ICH5080-50mg | Belimumab Biosimilar – Research Grade | 50mg |
| 1877 | ICH5080-5mg | Belimumab Biosimilar – Research Grade | 5mg |
| 1878 | ICH5081-100mg | Onvatilimab Biosimilar – Research Grade | 100mg |
| 1879 | ICH5081-10mg | Onvatilimab Biosimilar – Research Grade | 10mg |
| 1880 | ICH5081-1mg | Onvatilimab Biosimilar – Research Grade | 1mg |
| 1881 | ICH5081-20mg | Onvatilimab Biosimilar – Research Grade | 20mg |
| 1882 | ICH5081-50mg | Onvatilimab Biosimilar – Research Grade | 50mg |
| 1883 | ICH5081-5mg | Onvatilimab Biosimilar – Research Grade | 5mg |
| 1884 | ICH5082-100mg | Caplacizumab Biosimilar – Research Grade | 100mg |
| 1885 | ICH5082-10mg | Caplacizumab Biosimilar – Research Grade | 10mg |
| 1886 | ICH5082-1mg | Caplacizumab Biosimilar – Research Grade | 1mg |
| 1887 | ICH5082-20mg | Caplacizumab Biosimilar – Research Grade | 20mg |
| 1888 | ICH5082-50mg | Caplacizumab Biosimilar – Research Grade | 50mg |
| 1889 | ICH5082-5mg | Caplacizumab Biosimilar – Research Grade | 5mg |
| 1890 | ICH5083-100mg | Rosopatamab Biosimilar – Research Grade | 100mg |
| 1891 | ICH5083-10mg | Rosopatamab Biosimilar – Research Grade | 10mg |
| 1892 | ICH5083-1mg | Rosopatamab Biosimilar – Research Grade | 1mg |
| 1893 | ICH5083-20mg | Rosopatamab Biosimilar – Research Grade | 20mg |
| 1894 | ICH5083-50mg | Rosopatamab Biosimilar – Research Grade | 50mg |
| 1895 | ICH5083-5mg | Rosopatamab Biosimilar – Research Grade | 5mg |
| 1896 | ICH5084-100mg | Rolinsatamab Biosimilar – Research Grade | 100mg |
| 1897 | ICH5084-10mg | Rolinsatamab Biosimilar – Research Grade | 10mg |
| 1898 | ICH5084-1mg | Rolinsatamab Biosimilar – Research Grade | 1mg |
| 1899 | ICH5084-20mg | Rolinsatamab Biosimilar – Research Grade | 20mg |
| 1900 | ICH5084-50mg | Rolinsatamab Biosimilar – Research Grade | 50mg |
| 1901 | ICH5084-5mg | Rolinsatamab Biosimilar – Research Grade | 5mg |
| 1902 | ICH5085-100mg | Iratumumab Biosimilar – Research Grade | 100mg |
| 1903 | ICH5085-10mg | Iratumumab Biosimilar – Research Grade | 10mg |
| 1904 | ICH5085-1mg | Iratumumab Biosimilar – Research Grade | 1mg |
| 1905 | ICH5085-20mg | Iratumumab Biosimilar – Research Grade | 20mg |
| 1906 | ICH5085-50mg | Iratumumab Biosimilar – Research Grade | 50mg |
| 1907 | ICH5085-5mg | Iratumumab Biosimilar – Research Grade | 5mg |
| 1908 | ICH5086-100mg | Sofituzumab Biosimilar – Research Grade | 100mg |
| 1909 | ICH5086-10mg | Sofituzumab Biosimilar – Research Grade | 10mg |
| 1910 | ICH5086-1mg | Sofituzumab Biosimilar – Research Grade | 1mg |
| 1911 | ICH5086-20mg | Sofituzumab Biosimilar – Research Grade | 20mg |
| 1912 | ICH5086-50mg | Sofituzumab Biosimilar – Research Grade | 50mg |
| 1913 | ICH5086-5mg | Sofituzumab Biosimilar – Research Grade | 5mg |
| 1914 | ICH5087-100mg | Bexmarilimab Biosimilar – Research Grade [ICH5087] | 100mg |
| 1915 | ICH5087-10mg | Bexmarilimab Biosimilar – Research Grade [ICH5087] | 10mg |
| 1916 | ICH5087-1mg | Bexmarilimab Biosimilar – Research Grade [ICH5087] | 1mg |
| 1917 | ICH5087-20mg | Bexmarilimab Biosimilar – Research Grade [ICH5087] | 20mg |
| 1918 | ICH5087-50mg | Bexmarilimab Biosimilar – Research Grade [ICH5087] | 50mg |
| 1919 | ICH5087-5mg | Bexmarilimab Biosimilar – Research Grade [ICH5087] | 5mg |
| 1920 | ICH5088-100mg | Nadunolimab Biosimilar – Research Grade | 100mg |
| 1921 | ICH5088-10mg | Nadunolimab Biosimilar – Research Grade | 10mg |
| 1922 | ICH5088-1mg | Nadunolimab Biosimilar – Research Grade | 1mg |
| 1923 | ICH5088-20mg | Nadunolimab Biosimilar – Research Grade | 20mg |
| 1924 | ICH5088-50mg | Nadunolimab Biosimilar – Research Grade | 50mg |
| 1925 | ICH5088-5mg | Nadunolimab Biosimilar – Research Grade | 5mg |
| 1926 | ICH5089-100mg | Pivekimab Biosimilar – Research Grade | 100mg |
| 1927 | ICH5089-10mg | Pivekimab Biosimilar – Research Grade | 10mg |
| 1928 | ICH5089-1mg | Pivekimab Biosimilar – Research Grade | 1mg |
| 1929 | ICH5089-20mg | Pivekimab Biosimilar – Research Grade | 20mg |
| 1930 | ICH5089-50mg | Pivekimab Biosimilar – Research Grade | 50mg |
| 1931 | ICH5089-5mg | Pivekimab Biosimilar – Research Grade | 5mg |
| 1932 | ICH5090-100mg | Camidanlumab Biosimilar – Research Grade | 100mg |
| 1933 | ICH5090-10mg | Camidanlumab Biosimilar – Research Grade | 10mg |
| 1934 | ICH5090-1mg | Camidanlumab Biosimilar – Research Grade | 1mg |
| 1935 | ICH5090-20mg | Camidanlumab Biosimilar – Research Grade | 20mg |
| 1936 | ICH5090-50mg | Camidanlumab Biosimilar – Research Grade | 50mg |
| 1937 | ICH5090-5mg | Camidanlumab Biosimilar – Research Grade | 5mg |
| 1938 | ICH5091-100mg | Indusatumab Biosimilar – Research Grade | 100mg |
| 1939 | ICH5091-10mg | Indusatumab Biosimilar – Research Grade | 10mg |
| 1940 | ICH5091-1mg | Indusatumab Biosimilar – Research Grade | 1mg |
| 1941 | ICH5091-20mg | Indusatumab Biosimilar – Research Grade | 20mg |
| 1942 | ICH5091-50mg | Indusatumab Biosimilar – Research Grade | 50mg |
| 1943 | ICH5091-5mg | Indusatumab Biosimilar – Research Grade | 5mg |
| 1944 | ICH5092-100mg | Edrecolomab Biosimilar – Research Grade | 100mg |
| 1945 | ICH5092-10mg | Edrecolomab Biosimilar – Research Grade | 10mg |
| 1946 | ICH5092-1mg | Edrecolomab Biosimilar – Research Grade | 1mg |
| 1947 | ICH5092-20mg | Edrecolomab Biosimilar – Research Grade | 20mg |
| 1948 | ICH5092-50mg | Edrecolomab Biosimilar – Research Grade | 50mg |
| 1949 | ICH5092-5mg | Edrecolomab Biosimilar – Research Grade | 5mg |
| 1950 | ICH5093-100mg | Pinatuzumab Biosimilar – Research Grade | 100mg |
| 1951 | ICH5093-10mg | Pinatuzumab Biosimilar – Research Grade | 10mg |
| 1952 | ICH5093-1mg | Pinatuzumab Biosimilar – Research Grade | 1mg |
| 1953 | ICH5093-20mg | Pinatuzumab Biosimilar – Research Grade | 20mg |
| 1954 | ICH5093-50mg | Pinatuzumab Biosimilar – Research Grade | 50mg |
| 1955 | ICH5093-5mg | Pinatuzumab Biosimilar – Research Grade | 5mg |
| 1956 | ICH5094-100mg | Upifitamab Biosimilar – Research Grade | 100mg |
| 1957 | ICH5094-10mg | Upifitamab Biosimilar – Research Grade | 10mg |
| 1958 | ICH5094-1mg | Upifitamab Biosimilar – Research Grade | 1mg |
| 1959 | ICH5094-20mg | Upifitamab Biosimilar – Research Grade | 20mg |
| 1960 | ICH5094-50mg | Upifitamab Biosimilar – Research Grade | 50mg |
| 1961 | ICH5094-5mg | Upifitamab Biosimilar – Research Grade | 5mg |
| 1962 | ICH5095-100mg | Omburtamab Biosimilar – Research Grade | 100mg |
| 1963 | ICH5095-10mg | Omburtamab Biosimilar – Research Grade | 10mg |
| 1964 | ICH5095-1mg | Omburtamab Biosimilar – Research Grade | 1mg |
| 1965 | ICH5095-20mg | Omburtamab Biosimilar – Research Grade | 20mg |
| 1966 | ICH5095-50mg | Omburtamab Biosimilar – Research Grade | 50mg |
| 1967 | ICH5095-5mg | Omburtamab Biosimilar – Research Grade | 5mg |
| 1968 | ICH5096-100mg | Daxdilimab Biosimilar – Research Grade | 100mg |
| 1969 | ICH5096-10mg | Daxdilimab Biosimilar – Research Grade | 10mg |
| 1970 | ICH5096-1mg | Daxdilimab Biosimilar – Research Grade | 1mg |
| 1971 | ICH5096-20mg | Daxdilimab Biosimilar – Research Grade | 20mg |
| 1972 | ICH5096-50mg | Daxdilimab Biosimilar – Research Grade | 50mg |
| 1973 | ICH5096-5mg | Daxdilimab Biosimilar – Research Grade | 5mg |
| 1974 | ICH5097-100mg | Mirvetuximab Biosimilar – Research Grade | 100mg |
| 1975 | ICH5097-10mg | Mirvetuximab Biosimilar – Research Grade | 10mg |
| 1976 | ICH5097-1mg | Mirvetuximab Biosimilar – Research Grade | 1mg |
| 1977 | ICH5097-20mg | Mirvetuximab Biosimilar – Research Grade | 20mg |
| 1978 | ICH5097-50mg | Mirvetuximab Biosimilar – Research Grade | 50mg |
| 1979 | ICH5097-5mg | Mirvetuximab Biosimilar – Research Grade | 5mg |
| 1980 | ICH5098-100mg | Ieramilimab Biosimilar – Research Grade | 100mg |
| 1981 | ICH5098-10mg | Ieramilimab Biosimilar – Research Grade | 10mg |
| 1982 | ICH5098-1mg | Ieramilimab Biosimilar – Research Grade | 1mg |
| 1983 | ICH5098-20mg | Ieramilimab Biosimilar – Research Grade | 20mg |
| 1984 | ICH5098-50mg | Ieramilimab Biosimilar – Research Grade | 50mg |
| 1985 | ICH5098-5mg | Ieramilimab Biosimilar – Research Grade | 5mg |
| 1986 | ICH5099-100mg | Veltuzumab Biosimilar – Research Grade | 100mg |
| 1987 | ICH5099-10mg | Veltuzumab Biosimilar – Research Grade | 10mg |
| 1988 | ICH5099-1mg | Veltuzumab Biosimilar – Research Grade | 1mg |
| 1989 | ICH5099-20mg | Veltuzumab Biosimilar – Research Grade | 20mg |
| 1990 | ICH5099-50mg | Veltuzumab Biosimilar – Research Grade | 50mg |
| 1991 | ICH5099-5mg | Veltuzumab Biosimilar – Research Grade | 5mg |
| 1992 | ICH5100-100mg | Tovetumab Biosimilar – Research Grade | 100mg |
| 1993 | ICH5100-10mg | Tovetumab Biosimilar – Research Grade | 10mg |
| 1994 | ICH5100-1mg | Tovetumab Biosimilar – Research Grade | 1mg |
| 1995 | ICH5100-20mg | Tovetumab Biosimilar – Research Grade | 20mg |
| 1996 | ICH5100-50mg | Tovetumab Biosimilar – Research Grade | 50mg |
| 1997 | ICH5100-5mg | Tovetumab Biosimilar – Research Grade | 5mg |
| 1998 | ICH5101-100mg | Teplizumab Biosimilar – Research Grade | 100mg |
| 1999 | ICH5101-10mg | Teplizumab Biosimilar – Research Grade | 10mg |
| 2000 | ICH5101-1mg | Teplizumab Biosimilar – Research Grade | 1mg |